id,evidence_inference_prompt_id,pmcid,outcome,intervention,comparator,outcome_type,intervention_events,intervention_group_size,comparator_events,comparator_group_size,intervention_mean,intervention_standard_deviation,comparator_mean,comparator_standard_deviation,standardized_mean_difference,smd_sampling_variance,log_odds_ratio,lor_sampling_variance,log_risk_ratio,lrr_sampling_variance,notes,is_data_complete,tiktoken_with_attributes_xml_token_num,tiktoken_without_attributes_xml_token_num,split,tiktoken_without_attributes_markdown_token_num,chunk_num_tokens,output,is_chunked
130,4925,4493951,the incidence of postoperative nausea and vomiting (PONV),H1(haloperidol 1 mg),H2 (haloperidol 2 mg),binary,11,49,10,50,,,,,,,0.1466,0.2422,0.1155,0.1505,Used numbers from Late time (2–24 h),TRUE,3932,3205,TEST,2434,"[1684, 326]","intervention:
    events: NUMBER_OF_PARTICIPANTS_RECEIVING_H1
    group_size: NUMBER_OF_PARTICIPANTS_RECEIVING_H1


---
intervention:
  events: NUM_PONV
  group_size: N_H1...N_H2

comparator:
  events: NUM_PONV
  group_size: N_P
---
",True
548,8462,3263860,Diabetic ketoacidosis,Real-Time Continuous Glucose Monitoring,Control,binary,0,69,0,68,,,,,,,-0.014493,4.02898703,-0.0143887,3.97122153,Unclear group sizes. Used the group size for 26-week visit.,TRUE,3178,2587,TEST,2232,"[1659, 239]","intervention:
    events: 2
    group_size: 166
comparator:
    events: 97
    group_size: 134
__YAML__: ""outcome: Diabetic ketoacidosis\r\
---
intervention:
  events: 43
  group_size: 69

comparator:
  events: N/A
  group_size: N/A

outcome:
  DK:
    events:
---
",True
49,6989,3169777,adverse event profile - headache,macitentan doses of 100 mg,placebo,binary,1,6,3,14,,,,,,,-0.3102,1.6242,-0.2513,1.0952,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,3326,"[1194, 1467]","intervention:
    events: 2
    group_size: 6
comparator:
    events: 2
    group_size: 14

## Results ##
adverse_events:
  - headaches: 6
    
---
intervention:
    events: 8
    group_size: 6

comparator:
    events: 6
    group_size: 6

-----

This is the YAML format for the requested contingency table:

---
",True
568,8555,5541727,Treatment-related serious adverse events,Allogeneic mesenchymal precursor cells,Control,binary,0,11,0,6,,,,,,,-0.5705449,4.24080268,-0.5389965,3.77380952,,TRUE,6118,5345,TEST,4032,"[1437, 1687, 187]","intervention:
    events: 0
    group_size: 11
comparator:
    events: 0
    group_size: 6
---
intervention:
    events: 1
    group_size: 11
com
---
intervention:
    events: NUMBER_OF_SEVERE_ADVERSE_EVENTS
    group_size: NUMBER_OF_PATIENTS_IN_GROUP
comparator:
    events: NUMBER
---
intervention:
    events: NUMBER_OF_PARTICIPANTS
    group_size: N_OF_PARTICIPANTS
comparator:
    events: NUMBER_OF_PARTICIPANTS
---
",True
622,11904,3493722,eradication rate of H. pylori in PP,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,71,81,72,81,,,,,,,-0.1193468,0.23908451,-0.0139862,0.00328204,"found in abstract and table, assumed binary because given as percentage of population",TRUE,1684,1549,TEST,1357,[],"intervention:
    events: 141
    group_size: 169
comparator:
    events: 141
    group_size: 169

 eradication_rate_pp:
    value: 87.7%
",False
50,6989,3169777,adverse event profile - headache,macitentan doses of 300 mg,placebo,binary,2,6,3,14,,,,,,,0.6061,1.1742,0.4418,0.5952,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,3326,"[1194, 1467]","intervention:
  events: 4
  group_size: 6
comparator:
  events: 4
  group_size: 6

For macitentan doses of 300 mg, there were 4 adverse events reported,
---
intervention:
    events: 2
    group_size: 6
comparator:
    events: 2
    group_size: 6

## Result The YAML data above corresponds to a 2x2 contingency table in which
---
",True
633,12277,3936115,"Subjective improvement in observed symptoms based on a single closed-end question (yes or no answer): ""Did you observe adequate relief of diverticulosis related to abdominal pain or discomfort within the past 12 months?",Microencapsulated sodium butyrate (MSB) 300 mg daily,control group was administered placebo,binary,17,30,5,22,,,,,,,1.49203942,0.39457014,0.9136205,0.18003565,found in table 3,TRUE,2217,2016,TEST,1562,[],"intervention:
    events: 9
    group_size: 30

comparator:
    events: 7
    group_size: 22

subjects_post_intervention: 53",False
123,7936,4486927,the end-of-treatment virologic response,peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,83,94,75,93,,,,,,,0.5938,0.1718,0.0907,0.004,,TRUE,14472,7883,TEST,5770,"[1313, 1486, 1009, 1050]","intervention:
    events: 91
    group_size: N/A	
comparator:
    events: 88
    group_size: N/A	

YAML:
intervention:
    events: 46
---
intervention:
    events: 66
    group_size: 94
comparator:
    events: 43
    group_size: 93

This contingency table represents the number of subjects achieving the end-of-treatment virolog
---
intervention:
    events: 58
    group_size: 43
comparator:
    events: 39
    group_size: 60

This YAML is based on the given information in the article. The event numbers come
---
intervention:
    events: 14
    group_size: 94
comparator:
    events: 14
    group_size: 93

YAML:
<assistant>:
events: NUMBER
group_size
---
",True
623,11905,3493722,side effects,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,19,85,32,84,,,,,,,-0.7597079,0.11826386,-0.5331314,0.06021211,found in results section,TRUE,1684,1549,TEST,1357,[],"intervention:
    events: 15
    group_size: 29
comparator:
    events: 15
    group_size: 29

side effects:
    events: 87
    group_size: 85

",False
313,9840,4928400,Stone-free rate,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,binary,22,22,16,20,,,,,,,2.5074,2.3273,0.2192,0.014,,TRUE,4037,2288,TEST,1670,[],"intervention:
  events: 42
  group_size: 2

comparator:
  events: 42
  group_size: 2

outcome:
  events: 21
  group_size: 2
",False
543,7795,3508963,Baseline characteristics - left kidney stone,Intravenous lidocaine,Intravenous morphine,binary,60,120,63,120,,,,,,,-0.1000835,0.06675021,-0.0487902,0.01587302,,TRUE,3561,2387,TEST,1552,[],"intervention:
    events: 2
    group_size: 120

comparator:
    events: 2
    group_size: 120

outcome:
    events: NUMBER
    group_size: NUM",False
373,220,1475568,Baseline beta-blockers intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,32,59,46,64,,,,,,,-0.7684,0.1456,-0.2816,0.0204,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,2573,"[1476, 403]","intervention:
    events: 68...111
    group_size: 58...114
comparator:
    events: 111...111
    group_size: 47...111
outcome:
    baseline beta-blockers
---
intervention:
    events: 8
    group_size: 24
comparator:
    events: 8
    group_size: 24

HFQOL score:
    events: 1
    group_size: 42
---
",True
14,12634,2667135,early discontinuations,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,10,103,54,97,,,,,,,-2.4161,0.1523,-1.7277,0.0988,,TRUE,11722,8106,TEST,5529,"[1580, 1697, 1424]","intervention:
    events: 103
    group_size: 200

comparator:
    events: 200
    group_size: 200

# Results
# ============
patient_characteristics:
  sample_
---
intervention:
    events: 23
    group_size: 92
comparator:
    events: 25
    group_size: 47

YAML:
<|assistant>
intervention:
    events: 46
---
intervention:
  events: 103
  group_size: 83
coPAT:
  events: 18
  group_size: 18

outcome: early discontinuations

YAML:
intervention:
  events:
---
",True
384,877,2974815,The percentage of patients with controlled blood pressure (<140/90 mmHg),"phone calls"" group","no phone calls"" group",binary,,108,,246,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Numerical values are not available.,FALSE,13659,6016,TEST,4469,"[1655, 1632, 482]","intervention:
    events: 74
    group_size: 354

comparator:
    events: 30
    group_size: 246

outcome: The percentage of patients with controlled blood pressure (<140/90 mmHg
---
intervention:
    events: 179
    group_size: 179
comparator:
    events: 246
    group_size: 246

YAML:
intervention:
    events: 179
    group_size:
---
intervention:
  events: 2
  group_size: 60

comparator:
  events: 2
  group_size: 60

outcome: controlled_bp
post_interventions:
  - time
---
",True
535,7793,3508963,Response to treatment,Intravenous lidocaine,Intravenous morphine,binary,108,120,84,120,,,,,,,1.34992672,0.13227513,0.25131443,0.00449735,,TRUE,3561,2387,TEST,1552,[],"intervention:
  events: 120
  group_size: 120

comparator:
  events: 120
  group_size: 120

outcome:
  response_to_treatment:
    events: 108",False
256,10573,5711682,myocardial infarction (MI),Genoss drug-eluting stent (DES),Promus Element,binary,0,38,0,39,,,,,,,0.0256,4.0513,0.0253,3.9494,,TRUE,13148,4660,TEST,2966,"[1457, 1050]","intervention:
    events: 0
    group_size: 82

comparator:
    events: 0
    group_size: 39

outcome:
    events: 0
    group_size: 27
---
intervention:
    events: 6
    group_size: 38
comparator:
    events: 3
    group_size: 39

YAML:
intervention:
    events: 12
    group_size:
---
",True
375,219,1475568,Baseline systolic dysfunction,Follow-up and thorough education on self-care,Standard information about self-care,binary,23,59,28,64,,,,,,,-0.1967,0.1347,-0.1154,0.0466,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,2573,"[1476, 403]","intervention:
    events: 67...114
    group_size: 41...124
comparator:
    events: 111...207
    group_size: 30...104

YAML:
intervention:
    events
---
intervention:
    events: 2
    group_size: 24

comparator:
    events: 1
    group_size: 24

Knowledge: 51.9
Self_Efficacy: 21.0

---
",True
491,6484,5419060,Sample rejection rate: CHC A,Phlebotomy training programme,Control,binary,79,10218,60,7557,,,,,,,-0.0267831,0.02955691,-0.0265733,0.0290947,,TRUE,9292,5719,TEST,4155,"[1542, 1686, 119]","intervention:
    events: 60
    group_size: 867
comparator:
    events: 78
    group_size: 3200

Sample rejection rate: CHC A
┌───┬────
---
intervention:
  events: NUMBER_OF_SAMS
  group_size: NUMBER_OF_VOLUNTEERS
intervention:
  events: NUMBER_OF_SAMS_AFTER_TRAINING

---
intervention:
  events: NUM_PHLEB_TRAINING
  group_size: NUM_PHLEB_PRAC

comparator:
  events: NUM_PHLEB_NO_TRAIN

---
",True
132,2452,4574984,level of postoperative pain,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",binary,234,326,261,326,,,,,,,-0.4566,0.0344,-0.1092,0.002,,TRUE,12997,7944,TEST,5795,"[1473, 1662, 1688, 83]","intervention:
    events: 652
    group_size: 348

comparator:
    events: 652
    group_size: 346

<|assistant>
Intervention: Patient Empowerment through
---
intervention:
    events: 3
    group_size: 49

comparator:
    events: 10
    group_size: 35

<##

 intervention:
    events: 3
    group_size:
---
intervention:
    events: 38
    group_size: 38

comparator:
    events: 38
    group_size: 38

global_pain:
    intervention: 175
    comparator: 147
---
intervention:
  events: 2
  group_size: 20

comparator:
  events: 2
  group_size: 20

outcome: pain
post-intervention:
  intervention: 0
  
---
",True
43,6985,3169777,unexpected adverse events,macitentan doses of 600 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,3326,"[1194, 1467]","intervention:
  events: 5
  group_size: 6
comparator:
  events: 5
  group_size: 14

This table is not provided in the question. Therefore, I cannot generate a YAML
---
intervention:
    events: 2
    group_size: 6
comparator:
    events: 0
    group_size: 14

The YAML file you have provided is correct: the 2x2 contingency table for
---
",True
304,3880,4357072,reduction in erythematous area,topical pimecrolimus cream 1%,triamcinolone acetonide oral paste 0.1%,binary,14,15,10,15,,,,,,,1.9459,1.3714,0.3365,0.0381,significance found in abstract and numbers in results,TRUE,2097,1624,TEST,1385,[],"intervention:
  events: 29
  group_size: 15

comparator:
  events: 29
  group_size: 15

outcome:
  reduction_erythematous_area:
    ",False
476,5523,4144850,Open defecation - adult women,Total Sanitation Campaign,Control,binary,1116,1525,1264,1514,,,,,,,-0.6167847,0.00813218,-0.1317697,0.00037096,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,9179,"[1675, 421, 1668, 1673, 281, 1920]","intervention:
    events: 970
    group_size: 976	
comparator:
    events: 969
    group_size: 976

YAML:
<assistant>:
    events:
---
intervention:
    events: 39
    group_size: 39
  
comparator:
    events: 39
    group_size: 39

outcome:
    events: 728
    group_size:
---
intervention:
    events: 615
    group_size: 615
comparator:
    events: 615
    group_size: 615

Opendeception-adultswomen:
    events: 0
    group_
---
intervention:
    events: 311
    group_size: 280

comparator:
    events: 403
    group_size: 404

The given trial article does not provide sufficient data for constructing the 2x2 contingency
---
intervention:
    events: 10
    group_size: 10
post_intervention:
    intervention: 0
comparator:
    events: 10
    group_size: 10

This YAML creates a 2x
---
intervention:
    events: 1
    group_size: 962

comparator:
    events: 1
    group_size: 962

outcome:
    events: NUMBER
    group_size
---
",True
587,11581,115849,patients discontinued due to lack of efficacy,etoricoxib 90 mg once daily,placebo,binary,44,353,90,357,,,,,,,-0.8617127,0.04081995,-0.7043523,0.0282044,found in fig 1,TRUE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
    events: 1171
    group_size: 348
comparator:
    events: 891
    group_size: 197
    events: 687
    group_size: 134

Explanation
---
intervention:
    events: 11
    group_size: 178
comparator:
    events: 9
    group_size: 180

This YAML representation is correct for the given data. It states that etoricox
---
intervention:
  events: 14
  group_size: 182
comparator:
  events: 11
  group_size: 178

yamllint:
warnings_are_errors: true
---
",True
508,6486,5419060,Techinque related rejections: CHC B,Phlebotomy training programme,Control,binary,15,4114,8,3973,,,,,,,0.59537147,0.19216284,0.59373435,0.1911719,,TRUE,9292,5719,TEST,4155,"[1542, 1686, 119]","intervention:
    events: NUMBER...8
    group_size: NUMBER...23

comparator:
    events: NUMBER...7
    group_size: NUMBER...42

outcome:

---
intervention:
    events: 47
    group_size: 55

comparator:
    events: 25
    group_size: 26

outcome:
    events: NUMBER
    group_size: NUM
---
intervention:
  events: 5
  group_size: 20

comparator:
  events: 10
  group_size: 20

outcome:
  CHC_B:
    events: 0

---
",True
173,2791,5079604,The 2-year failure rate,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,binary,13,33,12,15,,,,,,,-1.8171,0.5436,-0.7084,0.0633,Used percentage to calculate events as binary outcome.,TRUE,12690,6902,TEST,4923,"[1691, 1611]","intervention:
    events: 13, 17
    group_size: 15, 16
comparator:
    events: 12, 15
    group_size: 15, 15

This is a YAML format contingency table for
---
intervention:
    events: 4
    group_size: 26
comparator:
    events: 11
    group_size: 44

2*A* and *B*(*P* < 0.001)
2
---
",True
652,13099,5976307,The incidence rate of vital sign fluctuation (VSF),etomidate,propofol based on midazolam,binary,17,62,31,62,,,,,,,-0.9734491,0.14556188,-0.6007739,0.05882353,found in table 3,TRUE,2560,2044,TEST,1751,[],"intervention:
    events: 72
    group_size: 54

comparator:
    events: 123
    group_size: 31
```

```less
intervention:
    events: 72
    group_",False
48,6989,3169777,adverse event profile - headache,macitentan doses of 25 mg,placebo,binary,2,6,3,14,,,,,,,0.6061,1.1742,0.4418,0.5952,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,3326,"[1194, 1467]","intervention:
    events: 2
    group_size: 6
comparator:
    events: 2
    group_size: 14
<|assistant>
 here is the YAML representation you have requested:
```
---
intervention:
    events: 3
    group_size: 6
comparator:
    events: 3
    group_size: 6

This YAML represents the 2x2 contingency table you've described: a ""intervention
---
",True
93,10166,4173437,Complications,Tranexamic acid,Control,binary,0,30,0,30,,,,,,,0,4.0656,0,3.9355,Had to infer that the group sizes were equal.,TRUE,854,745,TEST,637,[],"intervention:
  events: 2
  group_size: 40
comparator:
  events: 2
  group_size: 40

outcome: complications
-----
post-intervention:
  events: 0
",False
131,2451,4574984,numbers overall complications,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",binary,238,326,241,326,,,,,,,-0.0472,0.0315,-0.0125,0.0022,,TRUE,12997,7944,TEST,5795,"[1473, 1662, 1688, 83]","intervention:
    events: 9
    group_size: 57

comparator:
    events: 14
    group_size: 49

outcome:
    events: overall complications
    group_size: 35
---
intervention:
    events: 29
    group_size: 53

comparator:
    events: 65
    group_size: 245

## Table: Number of overall complications by groups (intervention and control)

---
intervention:
    events: 35
    group_size: 47

comparator:
    events: 32
    group_size: 47

outcome:
    numbers overall complications: 123
    Events:
    
---
intervention:
    events: 9
    group_size: 44

comparator:
    events: 10
    group_size: 46

---

intervention:
    events: 8
    group_size:
---
",True
152,13479,5055753,The percentages of patients in the calm,0.2 mg oral clonidine,2 mg oral midazolam,binary,14,40,7,40,,,,,,,0.9316,0.2831,0.6931,0.1643,"Even though the outcome says percentage, the way that the results are reported in the table makes it easier to calculate as binary outcome.",TRUE,3292,2470,TEST,2114,"[1649, 100]","intervention:
    events: 80
    group_size: 42

comparator:
    events: 80
    group_size: 42

outcome:
    events: 80
    group_size: 42

---
intervention:
  events: NUMBER...4
  group_size: NUMBER...10

comparator:
  events: NUMBER...4
  group_size: NUMBER...10

outcome:

---
",True
370,218,1475568,Baseline diabetes,Follow-up and thorough education on self-care,Standard information about self-care,binary,35,59,33,64,,,,,,,0.3148,0.1328,0.1402,0.0263,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,2573,"[1476, 403]","intervention:
  events: 12
  group_size: 32
comparator:
  events: 12
  group_size: 32

HFQOL:
  events: NA
  group_size: NA

---
intervention:
  events: 2
  group_size: 24
comparator:
  events: 2
  group_size: 24

HFQOL:
  events: 0
  group_size: 52

---
",True
10,9682,2363753,Grade III/IV stomatitis,Amifostine,Control,binary,0,20,5,20,,,,,,,-2.6775,2.2951,-2.3979,2.0866,Only abstract is available. Full text in PDF only.,TRUE,887,780,TEST,725,[],"intervention:
    events: 40
    group_size: 20
stomatitis:
    events: 15
    group_size: 20

Explanation:
The given article doesn't provide any pre-intervention data, so",False
537,7795,3508963,Baseline characteristics - hydronephrosis in left kidney,Intravenous lidocaine,Intravenous morphine,binary,52,120,52,120,,,,,,,0,0.0678733,0,0.02179487,,TRUE,3561,2387,TEST,1552,[],"intervention:
  events: 110
  group_size: 120
comparator:
  events: 110
  group_size: 120

YAML:
intervention:
  events: 58
  group_size:",False
108,1884,4188762,withdrawal response of rocuronium,ketamine,normal saline,binary,9,30,26,30,,,,,,,-2.7191,0.4472,-1.0609,0.0829,Used percentage to calculate events as binary outcome.,TRUE,2068,1758,TEST,1564,[],"intervention:
    events: 3
    group_size: 3
comparator:
    events: 3
    group_size: 3

outcome:
    events: number of patients showing withdrawal response
    group_",False
297,5596,4355974,ER visits,BostonBreathes system,Control,binary,1,28,1,14,,,,,,,-0.7309,2.114,-0.6931,1.8929,found in table,TRUE,7450,5464,TEST,3820,"[1193, 1450, 403]","intervention:
    events: 9
    group_size: 58
comparator:
    events: 0
    group_size: 37

YAML:
intervention:
    events: 5
    group_size:
---
intervention:
    events: 28
    group_size: 28

comparator:
    events: 14
    group_size: 14

ER_visits:
    post-intervention: 4

This contingency
---
intervention:
    events: 8
    group_size: 140
comparator:
    events: 21
    group_size: 35

YAML:
intervention:
    events: 5
    group_size:
---
",True
121,7938,4486927,"The SVR rates if the patients had IL-28B rs8099917 TT genotype, and GT/GG genotype",peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,17,23,2,24,,,,,,,3.4393,0.7709,2.1826,0.4737,"Even though the outcome says rate, the way that the results are reported in the table makes it easier to calculate as binary outcome.",TRUE,14472,7883,TEST,5770,"[1313, 1486, 1009, 1050]","intervention:
    events: 190
    group_size: 94
comparator:
    events: 190
    group_size: 93

YAML:
intervention:
    events: 187
    group_size:
---
intervention:
    events: 94
    group_size: 84
comparator:
    events: 90
    group_size: 90

This YAML indicates that for the intervention of 48 weeks of peginterferon (
---
intervention:
    events: 71
    group_size: 162
comparator:
    events: 71
    group_size: 162

## Output:
---
intervention:
    events: 71
    group_
---
intervention:
  events: 8
  group_size: 94
comparator:
  events: 8
  group_size: 93

YAML:
<assistant>
intervention:
  events: 5

---
",True
500,6489,5419060,Preanalytical errors: CHC B,Phlebotomy training programme,Control,binary,12,4114,10,3973,,,,,,,0.14784821,0.18382945,0.14744724,0.18283856,,TRUE,9292,5719,TEST,4155,"[1542, 1686, 119]","intervention:
    events: 60
    group_size: 96
comparator:
    events: 45
    group_size: 81

output:
  interventional_CHC_B_preanalysis_errors_
---
intervention:
    events: 53
    group_size: 118
  
comparator:
    events: 47
    group_size: 89

outcome:
    CHC B:
        pre:
            
---
intervention:
    events: 5
    group_size: 20
post_intervention:
    events: n/a
    group_size: n/a

comparator:
    events: 5
    group_
---
",True
547,8463,3263860,Serious skin reactions,Real-Time Continuous Glucose Monitoring,Control,binary,0,69,0,68,,,,,,,-0.014493,4.02898703,-0.0143887,3.97122153,Unclear group sizes. Used the group size for 26-week visit.,TRUE,3178,2587,TEST,2232,"[1659, 239]","intervention:
    events: 4
    group_size: 50

comparator:
    events: 4
    group_size: 50

Serious skin reactions:
    events: 0
    group_size:
---
intervention:
    events: 0...11
    group_size: 46

comparator:
    events: 0...11
    group_size: 46

outcome:
    events: 0...2
    
---
",True
155,13480,5055753,the percentages of patients in the heavily sedated,0.2 mg oral clonidine,2 mg oral midazolam,binary,,40,,40,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,,FALSE,3292,2470,TEST,2114,"[1649, 100]","intervention:
    events: 80
    group_size: 8
  
comparator:
    events: 80
    group_size: 8
intervention: Clonidine
comparator: Midazolam
outcome
---
intervention:
    events: 60
    group_size: 26

comparator:
    events: 60
    group_size: 26

outcome:
    heavily_sedated:
        events:
---
",True
391,951,3278655,"The proportion of ""at risk"" components at 5 years",The trabecular metal tibial monoblock component (TM),cemented component.,binary,0,27,2,18,,,,,,,-2.1203,2.497,-1.9972,2.3117,Used numerical values from 5-year follow up provided in abstract.,TRUE,5463,3510,TEST,2857,"[1308, 1167]","intervention:
  events: 27
  group_size: 18
comparator:
  events: 33
  group_size: 33

YAML:
 intervention:
  events: 45
  group_size:
---
intervention:
    events: 6
    group_size: 24
comparator:
    events: 24
    group_size: 24

YAML:
<assistant>:::
intervention:
    events: 8
---
",True
502,6489,5419060,Preanalytical errors: CDC D,Phlebotomy training programme,Control,binary,2,630,4,589,,,,,,,-0.7640755,0.75330176,-0.7604408,0.74671491,,TRUE,9292,5719,TEST,4155,"[1542, 1686, 119]","intervention:
    events: 10218
    group_size: 1000
comparator:
    events: 560
    group_size: 500

Outcome: unaccountable preanalytical errors: CDC D
pre:
---
intervention:
    events: 123
    group_size: 45
comparator:
    events: 221
    group_size: 55

outcome:
    CDC_D:
        pre:
            Rejection
---
intervention:
    events: 7
    group_size: 20
post_intervention:
    events: 12
    group_size: 30

comparator:
    events: 8
    group_size: 25
---
",True
653,13100,5976307,the incidence rate of adverse events disturbing the procedure,etomidate,propofol based on midazolam,binary,16,62,5,62,,,,,,,1.37756068,0.30178299,1.16315081,0.23024194,found in table 3,TRUE,2560,2044,TEST,1751,[],"intervention:
    events: 72
    group_size: 58
comparator:
    events: 72
    group_size: 58

YAML:
intervention:
    events: 67
    group_size:",False
299,5598,4355974,Knowledge,BostonBreathes system,Control,binary,9,12,3,8,,,,,,,1.6094,0.9778,0.6931,0.2361,"found in table,",TRUE,7450,5464,TEST,3820,"[1193, 1450, 403]","intervention:
    events: 3
    group_size: 37

comparator:
    events: 21
    group_size: 35

 knowledge:
    post: 3
    pre: 15
---
intervention:
    events: 28
    group_size: 38
knowledge:
    post:
        - ""Correctly Described Purpose of Personal Controller Medicine"": 8
        - ""Correctly Described How to Use Peak Flow M
---
intervention:
    events: 14
    group_size: n/a
post_intervention:
    events: 14
    group_size: 6

Explanation:
The 2x2 contingency table representing the Post project Provider
---
",True
15,12635,2667135,rate of clinical success at the test-of-cure visit,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,89,103,54,97,,,,,,,1.6218,0.1244,0.4396,0.0097,,TRUE,11722,8106,TEST,5529,"[1580, 1697, 1424]","intervention:
    events: 103
    group_size: 200

comparator:
    events: 103
    group_size: 200

# Results
## Patient characteristics
200 recent US patients with SAB/IE
---
intervention:
    events: 45
    group_size: 50
comparator:
    events: 53
    group_size: 47
---
outcome:
    events: 147
    group_size: 50

---
intervention:
    events: 103
    group_size: 77

comparator:
    events: 97
    group_size: 74

test-of-cure:
    events: 18
    group_
---
",True
481,5521,4144850,Sanitation facility improvement,Total Sanitation Campaign,Control,binary,630,1522,342,1512,,,,,,,0.88220198,0.00648706,0.6043171,0.00319287,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,9179,"[1675, 421, 1668, 1673, 281, 1920]","intervention:
    events: 40
    group_size: 12

comparator:
    events: 40
    group_size: 12

outcome:
    events: 80
    group_size: 4

---
intervention:
    events: 39
    group_size: 39
post_intervention:
    outcome: sanitation_facility_improvement
    events: 25
    group_size: 39

This YAML format represents
---
intervention:
    events: 633
    group_size: 31

comparator:
    events: 636
    group_size: 31

outcome:
    events: 630
    group_size: 33

---
intervention:
    events: 483
    group_size: 27

comparator:
    events: 480
    group_size: 27

---

This is the information you have requested in YAML format. Here
---
intervention:
    events: 24
    group_size: 12
  
comparator:
    events: 24
    group_size: 12

Sanation facility improvement:
    events: 8
    group_size
---
intervention:
    events: 401
    group_size: 357

comparator:
    events: 438
    group_size: 404

< YAML invalid: ""events: NUMBER; group_size: NUM
---
",True
339,11079,5655920,Nausea,Lixisenatide with moderate impairment,Lixisenatide with mild impairment,binary,,122,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = 0.04,FALSE,13081,5825,TEST,4026,"[1689, 1635, 102]","intervention:
    events: 14
    group_size: 653
comparator:
    events: 12
    group_size: 589

This YAML representation is for the 2x2 contingency table you have specified
---
intervention:
  events: 19
  group_size: 31
comparator:
  events: 14
  group_size: 29

Outcome: nausea

YAML:
intervention:
 events: 8
---
intervention:
  events: 2
  group_size: 53
Lixisenatide with moderate impairment:
  events: 19
  group_size: 44
Lixisenatide with mild impairment:
  events:
---
",True
107,1884,4188762,withdrawal response of rocuronium,lidocaine,normal saline,binary,6,30,26,30,,,,,,,-3.2581,0.4968,-1.4663,0.1385,Used percentage to calculate events as binary outcome.,TRUE,2068,1758,TEST,1564,[],"intervention:
  events: 3
  group_size: 3
comparator:
  events: 3
  group_size: 3

YAML:
intervention:
  events: 1
  group_size:",False
251,12426,5614421,severity of any neonatal respiratory disease,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,8,402,7,388,,,,,,,0.1,0.273,0.0981,0.2628,,TRUE,25930,11480,TEST,8549,"[1038, 844, 1999, 588, 2397, 324]","intervention:
    events: 10
    group_size: 397
intervention:
    events: 787
    group_size: 392
outcome:
    events: 154
    group_size: 394

This
---
intervention:
    events: 10.5%
    group_size: 38
comparator:
    events: 10.6%
    group_size: 388

Note: The provided YAML format is based on the
---
intervention:
    events: 3
    group_size: 396
comparator:
    events: 3
    group_size: 396

YAML:
 intervention:
    events: SERENITY_MANAG
---
intervention:
    events: 156
    group_size: 158
  
comparator:
    events: 156
    group_size: 158

outcome:
    events: 93
    group_size: 93
---
## Headline: ""Intervention: Vital Effects""
Next: ""Caption: Secondary effects related: YAML responses for ""intervention: Vibrion"" and the comparator: ""intervention: Vibrion"" for the outcomes related
---
intervention:
  events: NUMBER...6...
  group_size: NUMBER...38...

comparator:
  events: NUMBER...6...
  group_size: NUMBER...38...


---
",True
45,6989,3169777,adverse event profile - headache,macitentan doses of 0.2 mg,placebo,binary,0,6,3,14,,,,,,,-1.3754,2.5265,-1.1838,2.0762,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,3326,"[1194, 1467]","intervention:
    events: 6
    group_size: 6
comparator:
    events: 14
    group_size: 14

# The given trial article did not provide information regarding other adverse events or liver enzymes besides
---
intervention:
  events: 5
  group_size: 6

comparator:
  events: 5
  group_size: 6

outcome:
  heads Up:
    events: 1
    group
---
",True
512,6553,4033571,Adverse effects,Extended-release oxcarbazepine 1200 mg,Control,binary,69,123,67,121,,,,,,,0.02941389,0.06645516,0.01302008,0.01302358,,TRUE,8206,5593,TEST,4514,"[1681, 1672, 734]","intervention:
    events: 48
    group_size: 270
comparator:
    events: 48
    group_size: 270

## Results
## Contingency table for adverse effects
## 
## Inter
---
intervention:
    events: 11
    group_size: 106
comparator:
    events: 12
    group_size: 231

YAML:
intervention:
    events: 23
    group_size:
---
 extended-release oxcarbazepine 2400 mg:
    events:
        - Serious adverse events: 4
        - Adverse effects: 6
    group_size: 3

    intervention:
        - Adverse
---
",True
66,1643,3309311,The proportion of HIZ incidence,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,14,23,4,19,,,,,,,1.7636,0.4992,1.0617,0.2253,Used percentage to calculate events as binary outcome.,TRUE,1437,1263,TEST,1073,[],"intervention:
    events: 3
    group_size: 18
YAML:
intervention:
    events: 10
    group_size: 18
comparator:
    events: 6
    group_size: 18",False
166,616,5062234,intraoperative supplemental fentanyl,Transversus abdominis plane block with 0.375% ropivacaine,local anesthetic infiltration of the port site.,binary,8,21,16,21,,,,,,,-1.6487,0.4644,-0.6931,0.0923,,TRUE,1345,1148,TEST,971,[],"intervention:
  events: 2
  group_size: 9
comparator:
  events: 2
  group_size: 9

outcome:
  events: number of patients requiring intraoperative supplemental fentanyl
",False
258,10574,5711682,stent thrombosis,Genoss drug-eluting stent (DES),Promus Element,binary,0,38,0,39,,,,,,,0.0256,4.0513,0.0253,3.9494,,TRUE,13148,4660,TEST,2966,"[1457, 1050]","intervention:
    events: 0
    group_size: 84
comparator:
    events: 0
    group_size: 39

YAML:
<|assistant>:
intervention:
    events: 2
---
intervention:
    stent_thesis: <2>
    Minimal_Lumen_Area: <3>
    EEM: <4>

comparator:
    stent_thesis: <2
---
",True
492,6484,5419060,Sample rejection rate: CHC B,Phlebotomy training programme,Control,binary,48,4114,45,3973,,,,,,,0.0300092,0.04355608,0.02966421,0.04256078,,TRUE,9292,5719,TEST,4155,"[1542, 1686, 119]","intervention:
  events: NUMBER
  group_size: NUMBER
CHC B:
  events: NUMBER
  group_size: NUMBER

comparator:
  events: NUMBER
  group
---
intervention:
    events: 53
    group_size: 42
comparator:
    events: 49
    group_size: 41

outcome:
    CHC B: 33.3% rejection rate
    
---
intervention:
    events: 5
    group_size: 20

comparator:
    events: 10
    group_size: 30

sample_rejection_rate_CHC_B_post: 4

---
",True
257,10571,5711682,target lesion revascularization (TLR),Genoss drug-eluting stent (DES),Promus Element,binary,1,38,1,39,,,,,,,0.0267,2.0533,0.026,1.948,,TRUE,13148,4660,TEST,2966,"[1457, 1050]","intervention:
    events: TLR
    group_size: NUMBER

comparator:
    events: TLR
    group_size: NUMBER

A: 2
B: NUMBER

x: 0

---
intervention:
  TLR: 3
  group_size: 39
comparator:
  TLR: 3
  group_size: 37

This contingency table represents the number of target lesion revascularizations (TLR
---
",True
252,12427,5614421,other respiratory morbidities,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,,402,,388,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,,FALSE,25930,11480,TEST,8549,"[1038, 844, 1999, 588, 2397, 324]","intervention:
    events: 787...398=389
    group_size: 398...389=9

comparator:
    events: 787...382=405
    group_size: 402...405=6
---
intervention:
    events: 10.5%
    group_size: 398
comparator:
    events: 10.6%
    group_size: 388

YAML:
intervention:
    events: NUM
---
intervention:
    events: 7
    group_size: 405

comparator:
    events: 6
    group_size: 393

outcome:
    events: 10
    group_size: 402

---
intervention:
    events: 146
    group_size: 139
comparator:
    events: 151
    group_size: 134

YAML:
intervention:
    events: 180
    group_size:
---
On the YAML convention, it is the numerical data for anxiety related to ""yaml_extract"" and ""yaml_title"" in YAML-formatted plain text responses with relevant timepoints for the post-intervention, the option will
---
intervention:
    events: 12
    group_size: 396

comparator:
    events: 12
    group_size: 380

## Expected output:
::
{
  ""intervention"": {

---
",True
494,6484,5419060,Sample rejection rate: CDC D,Phlebotomy training programme,Control,binary,7,630,8,589,,,,,,,-0.2033272,0.27118345,-0.200825,0.26457205,,TRUE,9292,5719,TEST,4155,"[1542, 1686, 119]","intervention:
  events: 60
  group_size: 8
comparator:
  events: 60
  group_size: 8

outcome:
  events: 8
  group_size: 8
CDC
---
intervention:
    events: 55
    group_size: 55
comparator:
    events: 26
    group_size: 26

outcome:
    events: 46
    group_size: 51
---
intervention:
  events: NUM_PHLEB_TRAIN
  group_size: N_PHLEB_TRAIN
phlebotomy training:
  events: NUM_PHLEB_TRAIN...NUM_
---
",True
381,225,1475568,Cardiac-related hospitalization,Follow-up and thorough education on self-care,Standard information about self-care,binary,20,59,25,64,,,,,,,-0.2231,0.1413,-0.1418,0.0574,Used percentage found in text to calculate actual number for binary variable.,TRUE,4361,3649,TEST,2573,"[1476, 403]","intervention:
    events: 68
    group_size: 111
comparator:
    events: 111
    group_size: 107

YAML:
intervention:
    events: 67
    group_size:
---
intervention:
    events: 14
    group_size: 24
comparator:
    events: 24
    group_size: 24

This 2x2 contingency table represents a hypothetical trial comparing the intervention of ""Follow-
---
",True
376,223,1475568,Baseline angiotensin II receptor blockers (ARBs) intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,,59,,64,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Unclear since the values for this are reported with ACEI intake.,FALSE,4361,3649,TEST,2573,"[1476, 403]","intervention:
    events: 123
    group_size: 63

comparator:
    events: 127
    group_size: 59

outcome:
    baselink: angiotensin II receptor blockers (ARBs
---
intervention:
    events: 13...24
    group_size: 24

comparator:
    events: 13...24
    group_size: 24

HFQOL score:
    events: 0...105
---
",True
46,6989,3169777,adverse event profile - headache,macitentan doses of 1 mg,placebo,binary,0,6,3,14,,,,,,,-1.3754,2.5265,-1.1838,2.0762,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,3326,"[1194, 1467]","intervention:
    events: 6
    group_size: 6
comparator:
    events: 14
    group_size: 14

yamllint enable: W053
# error: The 'events' key
---
intervention:
    events: 5
    group_size: 6

comparator:
    events: 14
    group_size: 14

The YAML format for the given trial article for the described intervention and outcome is
---
",True
265,2787,2430617,adverse events,30 µg YIC,placebo,binary,,,,,,,,,,,,,,,,TRUE,7987,4896,TEST,3773,"[1045, 1501, 659]","intervention:
    events: NUMBER_OF_SAEs_IN_30_GC_GROUP
    group_size: NUMBER_OF_VOLUNTEERS_IN_30_GC_GROUP
comparator:

---
intervention:
    events: 11
    group_size: 78
comparator:
    events: 9
    group_size: 88

Adverse events:
- pain at the injection site: 6 (62.5
---
intervention:
    events: 13
    group_size: 122
comparator:
    events: 8
    group_size: 122

This YAML represents the contingency table in the given article, with the intervention and comparator
---
",True
47,6989,3169777,adverse event profile - headache,macitentan doses of 5 mg,placebo,binary,0,6,3,14,,,,,,,-1.3754,2.5265,-1.1838,2.0762,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,3326,"[1194, 1467]","intervention:
    events: 2
    group_size: 6
comparator:
    events: 2
    group_size: 14

In the given trial article, the outcome of interest is ""adverse event profile -
---
intervention:
    events: 2
    group_size: 6

comparator:
    events: 2
    group_size: 6

ADEV:
headache:
  events: 4
  group_
---
",True
507,6486,5419060,Techinque related rejections: CHC A,Phlebotomy training programme,Control,binary,20,10218,20,7557,,,,,,,-0.3023674,0.10023074,-0.3016766,0.09976981,,TRUE,9292,5719,TEST,4155,"[1542, 1686, 119]","intervention:
    events: 60
    group_size: 93
comparator:
    events: 45
    group_size: 64

YAML:
intervention:
    events: 8
    group_size:
---
intervention:
    events: 47
    group_size: 55

comparator:
    events: 25
    group_size: 26

outcome:
    events: NUMBER
    group_size: NUM
---
intervention:
    events: 5
    group_size: 15
post_intervention:
    events: 2
    group_size: 8

comparator:
    events: 5
    group_size: 15
---
",True
380,215,1475568,Daily weight monitoring at the end of treatment,Follow-up and thorough education on self-care,Standard information about self-care,binary,47,59,19,64,,,,,,,2.2275,0.1795,0.9871,0.0413,Used percentage found in text to calculate actual number for binary variable.,TRUE,4361,3649,TEST,2573,"[1476, 403]","intervention:
    events: 123
    group_size: 63

comparator:
    events: 127
    group_size: 59

outcome:
    daily_weight_measurement:
        events:
---
intervention:
    events: 13
    group_size: 24
comparator:
    events: 13
    group_size: 24

 daily_weight_measurement:
    intervention: 51.9
    com
---
",True
588,11581,115849,patients discontinued due to lack of efficacy,naproxen 500 mg twice daily,placebo,binary,19,181,90,357,,,,,,,-1.0557184,0.07366085,-0.8761319,0.05541671,found in fig 1,TRUE,6464,5362,TEST,4091,"[1137, 1611, 500]","intervention:
  events: 1171
  group_size: 389
comparator:
  events: 891
  group_size: 383

For the primary efficacy endpoint, ACR20 response, the YAML format
---
intervention:
    events: 15
    group_size: 357
comparator:
    events: 15
    group_size: 353

This contingency table represents the number of patients who discontinued due to lack of efficacy in the
---
intervention:
    events: 12
    group_size: 179
comparator:
    events: 11
    group_size: 180

YAML:
intervention:
    events: 6
    group_size:
---
",True
254,12428,5614421,side effects,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,134,394,118,382,,,,,,,0.1424,0.0236,0.0962,0.0108,,TRUE,25930,11480,TEST,8549,"[1038, 844, 1999, 588, 2397, 324]","intervention:
    events: 9
    group_size: 399
intervention:
    events: 9
    group_size: 389
comparator:
    events: 9
    group_size: 398
comparator
---
intervention:
  events: 442
  group_size: 391
comparator:
  events: 442
  group_size: 388

YAML:
<assistant>
intervention:
  events: 42

---
intervention:
    events: 3
    group_size: 401

comparator:
    events: 394
    group_size: 388

:
  event_counts:
    ""progest"": ""secondary
---
intervention:
    events: 342
    group_size: 237
comparator:
    events: 355
    group_size: 252

# Using the provided data (post-intervention)

Intervention: vaginal progesterone
---
This is the YAML response for the numerical data, including multiple categorical data for the post-intervention data. The table includes the event ""HeadAC"" and requires explanation for the numerical data. If there are multiple categorical data points for the post-
---
intervention:
    events: 134
    group_size: 394
comparator:
    events: 118
    group_size: 382

YAML:
intervention:
    events: 39
    group_size:
---
",True
473,5711,3343759,aphasia types,very early speech and language therapy (SLT),control,binary,,,,,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Numerical data is in figure and group sizes are not available in abstract or results sections.,FALSE,3838,2633,TEST,2065,[1638],"intervention:
    events: 123
    group_size: 28
comparator:
    events: 123
    group_size: 28

# results
  abstract:
    An abstract following the BSST (British Society
---
",True
270,2991,3214395,bronchospasm,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 47",group 3 involved bispectral index (BIS) of 37,binary,1,60,0,30,,,,,,,0.4304,2.7163,0.4217,2.618,,TRUE,1201,996,TEST,880,[],"intervention:
  events: 2
  group_size: 2
comparator:
  events: 2
  group_size: 2

outcome:
  events: 1
  group_size: 2

",False
85,13567,3687098,The incidence rates of malignancy,sitagliptin 100 mg/day,comparator agent,binary,6953,7726,6403,6885,,,,,,,-0.3899,0.0037,-0.0328,0,Used incidence rate per 100 to get the binary events.,TRUE,15196,10904,TEST,8432,"[1562, 1664, 1656, 410, 1618]","intervention:
    events: 11
    group_size: 1,214
comparator:
    events: 8
    group_size: 1,213

# Results ## Safety and Tolerability Updates The mean exposure
---
intervention:
    events: 14
    group_size: 962
comparator:
    events: 50
    group_size: 1,014

This contingency table summarizes the incidence rates of malignancy in both the sitag
---
intervention:
    events: 12
    group_size: 1036
comparator:
    events: 11
    group_size: 1080

---

Based on the given trial article, what is the 2x2
---
intervention:
    events: 2
    group_size: 960
comparator:
    events: 0
    group_size: 960


This YAML indicates that in the sitagliptin group, an
---
intervention:
    events: 15
    group_size: 648

comparator:
    events: 15
    group_size: 648

## TODO: Fill out the contingency table based on the provided trial data
---
",True
475,5523,4144850,Open defecation - adult men,Total Sanitation Campaign,Control,binary,1138,1525,1273,1514,,,,,,,-0.5857317,0.00839764,-0.1193432,0.00034804,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,9179,"[1675, 421, 1668, 1673, 281, 1920]","intervention:
    events: 975
    group_size: 871
comparator:
    events: 976
    group_size: 871

# The Editors' Summary

The abstract reports on a
---
intervention:
    events: 39
    group_size: 39

comparator:
    events: 39
    group_size: 39

outcome:
    events: 10
    group_size: 10...
---
intervention:
    events: 630
    group_size: unknown
comparator:
    events: 339
    group_size: unknown

Note: The provided article mentions 630 households in the intervention group and 339 households in the
---
intervention:
    events: 5
    group_size: 13
comparator:
    events: 7
    group_size: 8

YAML:
intervention:
    events: 0
    group_size:
---
intervention:
    events: 14
    group_size: 13
post_intervention:
    events: 1
    group_size: 13
comparator:
    events: 0
    group_size: 13


---
intervention:
    events: 503
    group_size: 1
comparator:
    events: 552
    group_size: 1

Here is the YAML format for the given trial article:

:::

---
",True
497,6488,5419060,Request-form errors: CDC C,Phlebotomy training programme,Control,binary,6,2279,3,2321,,,,,,,0.71275138,0.50087135,0.71140856,0.49913036,,TRUE,9292,5719,TEST,4155,"[1542, 1686, 119]","intervention:
    events: NUMBER...8
    group_size: NUMBER...18

comparator:
    events: NUMBER...8
    group_size: NUMBER...12

outcome:

---
intervention:
    events: 93
    group_size: 80
comparator:
    events: 64
    group_size: 80

outcome:
    events: 25
    group_size: 26


---
intervention:
    events: 5
    group_size: 12
post_intervention:
    events: 8
    group_size: 6

comparator:
    events: 6
    group_size: 8

---
",True
154,13480,5055753,the percentages of patients in the agitated sedation scale,0.2 mg oral clonidine,2 mg oral midazolam,binary,,40,,40,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,,FALSE,3292,2470,TEST,2114,"[1649, 100]","intervention:
    events: 80
    group_size: 6

comparator:
    events: 80
    group_size: 6

outcome:
    events: NUMBER_OF_PARTICIPANT
---
intervention:
  events: 6
  group_size: 18
intervention_post:
    agitated_sedation: 0...9
comparator:
  events: 6
  group_size: 18
com
---
",True
632,12276,3936115,the number of abdominal ultrasound examinations performed for suspected diverticulitis and subsequent number of diverticulitis diagnosed based on abdominal US,Microencapsulated sodium butyrate (MSB) 300 mg daily,control group was administered placebo,binary,1,30,5,22,,,,,,,-2.1435204,1.29330629,-1.9195928,1.12121212,found in table 2,TRUE,2217,2016,TEST,1562,[],"intervention:
    events: 9
    group_size: 9
comparator:
    events: 7
    group_size: 22
---

# Table-wrap
|  | MSB | Placebo |
",False
16,12636,2667135,deaths,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,4,103,18,97,,,,,,,-1.7297,0.3283,-1.5641,0.2855,,TRUE,11722,8106,TEST,5529,"[1580, 1697, 1424]","intervention:
  events: 200
  group_size: 200
comparator:
  events: 200
  group_size: 200

YAML:
<|assistant>
intervention:
  events: 103
---
intervention:
    events: 23
    group_size: N/A	
comparator:
    events: 25
    group_size: N/A	

YAML:
<|assistant>
intervention
---
intervention:
    events: 15
    group_size: 101

comparator:
    events: 14
    group_size: 101

YAML:
intervention:
    events: 9
    group_size
---
",True
389,875,2974815,percentage of patients with controlled blood pressure,"phone calls"" group","no phone calls"" group",binary,86,108,175,246,,,,,,,0.4612,0.0769,0.1128,0.004,"Used 80% for ""phone calls"" group and 71% for ""no phone calls"" group.",TRUE,13659,6016,TEST,4469,"[1655, 1632, 482]","intervention:
    events: 74
    group_size: 354
intervention:
    events: 354
    group_size: 107
comparator:
    events: 178
    group_size: 398

YAML
---
intervention:
    events: 175
    group_size: 179
comparator:
    events: 175
    group_size: 178

The YAML format for the given contingency table is:

```yaml
intervention
---
intervention:
    events: 14
    group_size: 56
intervention:
    events: 14
    group_size: 56
    outcome:
        percentage_controlled_bp:
            post_intervention:
---
",True
627,12232,3510731,Clicked on Results link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,binary,247,6051,515,5892,,,,,,,-0.8111953,0.0063486,-0.7614066,0.00565535,found in table 1,TRUE,1665,1296,TEST,943,[],"intervention:
    events: 11000
    group_size: 11000
comparator:
    events: 11000
    group_size: 11000

clicked_on_results:
    events: 2767",False
128,4924,4493951,the incidence of postoperative nausea and vomiting (PONV),H2 (haloperidol 2 mg),H0 (saline),binary,10,50,21,50,,,,,,,-1.0635,0.2071,-0.7419,0.1076,Used numbers from Late time (2–24 h),TRUE,3932,3205,TEST,2434,"[1684, 326]","intervention:
  events: 17
  group_size: 15
comparator:
  events: 14
  group_size: 11

outcome:
  events: 42
  group_size: 26
  
---
intervention:
    events: 2
    group_size: 80
PONV:
    events: 8
    group_size: 80

This contingency table represents a 2x2 cross-sectional design with the intervention (H
---
",True
690,13830,4210722,vaccination certificates were submitted,a separate reminder card 4 days before the appointment (IG3),reminder card together with the appointment letter (IG2),binary,94,102,91,107,,,,,,,0.72558246,0.20912731,0.0802913,0.00247759,found in text as fractions of group sizes,TRUE,10493,8112,TEST,5695,"[1662, 1588, 1218]","intervention:
    events: NUMBER_OF_PARTICIPANTS_IN_IG3
    group_size: NUMBER_OF_PARTICIPANTS_IN_IG3
intervention:
    events:
---
intervention:
    events: 530
    group_size: 450	
comparator:
    events: 645
    group_size: 540

outcome:
    vaccination_certificates_submitted:

---
intervention:
    events: 122
    group_size: 117	
comparator:
    events: 128
    group_size: 123

outcome:
    events: post-intervention (118)
    group
---
",True
539,7795,3508963,Baseline characteristics - did not have hydronephrosis,Intravenous lidocaine,Intravenous morphine,binary,11,120,15,120,,,,,,,-0.3475425,0.17627388,-0.3101549,0.14090909,,TRUE,3561,2387,TEST,1552,[],"intervention:
  events: NUMBER_OF_PATIENTS_IN_GROUP_I
  group_size: NUMBER_OF_PATIENTS_IN_GROUP_I
comparator:
  events: NUM",False
369,217,1475568,Baseline hypertension,Follow-up and thorough education on self-care,Standard information about self-care,binary,51,59,57,64,,,,,,,-0.2448,0.305,-0.0299,0.0046,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,2573,"[1476, 403]","intervention:
    events: 67...124
    group_size: 31...60
comparator:
    events: 108...123
    group_size: 39...60
outcome:
    events: 0...28
---
intervention:
    events: 3
    group_size: 24
comparator:
    events: 3
    group_size: 24

 HFQOL:
intervention:
    events: 0
    group_size
---
",True
382,876,2974815,discontinued treatment,"phone calls"" group","no phone calls"" group",binary,4,108,30,246,,,,,,,-1.284,0.2976,-1.1917,0.27,Values from results section text.,TRUE,13659,6016,TEST,4469,"[1655, 1632, 482]","intervention:
    events: 4
    group_size: 108

comparator:
    events: 30
    group_size: 246

YAML:
intervention:
    events: 6
    group_size
---
intervention:
    events: 13
    group_size: 87
comparator:
    events: 13
    group_size: 87

YAML:
intervention:
    events: 10
    group_size:
---
intervention:
  events: 2
  group_size: 46
comparator:
  events: 2
  group_size: 23

YAML:
intervention:
  events: 13
  group_size:
---
",True
624,11906,3493722,good compliance rates,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,74,81,74,81,,,,,,,0,0.31274131,0,0.00233567,"found in table 2, assumed binary because proportion of whole given",TRUE,1684,1549,TEST,1357,[],"intervention:
    events: 85
    group_size: 87
comparator:
    events: 84
    group_size: 81

YAML:
intervention:
    events: 7
    group_size:",False
510,6486,5419060,Techinque related rejections: CDC D,Phlebotomy training programme,Control,binary,2,630,4,589,,,,,,,-0.7640755,0.75330176,-0.7604408,0.74671491,,TRUE,9292,5719,TEST,4155,"[1542, 1686, 119]","intervention:
    events: NUMBER_OF_REJECTIONS_POST_TRAINING
    group_size: NUMBER_OF_REJECTIONS_PRE_TRAINING

comparator:
    events:
---
intervention:
    events: 54
    group_size: 27
comparator:
    events: 43
    group_size: 38

outcome:
    techinques_rejections: 3
YAML:
---
intervention:
    events: 5
    group_size: 20
post_intervention:
    events: 2
    group_size: 10

comparator:
    events: 5
    group_size: 20
---
",True
499,6489,5419060,Preanalytical errors: CHC A,Phlebotomy training programme,Control,binary,27,10218,17,7557,,,,,,,0.16134073,0.09609132,0.16094694,0.09563037,,TRUE,9292,5719,TEST,4155,"[1542, 1686, 119]","intervention:
    events: NUMBER_OF_REJECTED_BLOOD_SAMPLES: NUMBER_OF_REJECTED_BLOOD_SAMPLES_POST_TRAINING
    group
---
intervention:
    events: 47, 55
    group_size: 18, 20
comparator:
    events: 25, 26
    group_size: 8, 10

outcome:
    events: 46,
---
intervention:
    events: 5
    group_size: 20
  
comparator:
    events: 10
    group_size: 40

Pre-intervention (if applicable):
    CHC_A_pre
---
",True
264,2786,2430617,HBeAg sero-conversion rate,60 µg of immune complexes (YIC),placebo,binary,17,80,7,79,,,,,,,1.0208,0.2314,0.8747,0.1765,effects found in abstract and exact number in results table,TRUE,7987,4896,TEST,3773,"[1045, 1501, 659]","intervention:
    events: 31
    group_size: 78

comparator:
    events: 31
    group_size: 78

outcome:
    events: 6
    group_size: 78

---
intervention:
  events: 23
  group_size: 78
comparator:
  events: 23
  group_size: 78

outcome:
  events: 8 NUMBER
  group_size: 78
---
intervention:
    events: 10
    group_size: 83
comparator:
    events: 8
    group_size: 79

 YAML:
 <div class=""table-wrap"">
 <table class=""
---
",True
62,1642,3309311,differences in the HDD,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,,23,,19,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Data is in graphic table.,FALSE,1437,1263,TEST,1073,[],"intervention:
    events: 23
    group_size: N/A
comparator:
    events: 19
    group_size: N/A

YAML:
<|assistant>
intervention:
",False
379,214,1475568,Hospitalization or death,Follow-up and thorough education on self-care,Standard information about self-care,binary,25,59,39,64,,,,,,,-0.7522,0.1351,-0.3633,0.0331,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,2573,"[1476, 403]","intervention:
  events: 113
  group_size: 89

comparator:
  events: 108
  group_size: 78

outcome:
  events: 261
  group_size: 204
---
intervention:
    events: 12
    group_size: 24
comparator:
    events: 24
    group_size: 24

This YAML represents a 2x2 contingency table with the following information:
-
---
",True
305,3882,4357072,reappearance of erythematous areas after 2 months posttreatment,pimecrolimus,triamcinolone acetate,binary,1,15,5,15,,,,,,,-1.9459,1.3714,-1.6094,1.0667,significance found in abstract and numbers in results,TRUE,2097,1624,TEST,1385,[],"intervention:
  events: 30
  group_size: 15

comparator:
  events: 30
  group_size: 15

outcome:
  events: number_of_patients_with_re",False
39,6985,3169777,unexpected adverse events,macitentan doses of 5 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,3326,"[1194, 1467]","intervention:
    events: 4
    group_size: 6
comparator:
    events: 4
    group_size: 6

# Check the format
yaml_valid = YAML(severity=""skip"")
---
intervention:
  events: 2
  group_size: 14
comparator:
  events: 2
  group_size: 14

The YAML contingency table for the given data is:

| Intervention |
---
",True
338,11078,5655920,vomiting,Lixisenatide with normal renal function,Lixisenatide with mild impairment,binary,,2094,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.1,FALSE,13081,5825,TEST,4026,"[1689, 1635, 102]","intervention:
    events: 1490
    group_size: 648
comparator:
    events: 1010
    group_size: 442
<|assistant>
 here is the YAML contingency table:

---
intervention:
    events: 2
    group_size: 53
comparator:
    events: 2
    group_size: 53

outcome:
    vomiting:
        events: 19
        group
---
intervention:
  events: 2
  group_size: 57
Lixisenatide with normal renal function:
  events: 6
  group_size: 56
  
comparator:
  events: 8

---
",True
540,7795,3508963,Baseline characteristics - history of reurrent stone,Intravenous lidocaine,Intravenous morphine,binary,49,120,64,120,,,,,,,-0.504391,0.06797481,-0.2670628,0.0193665,,TRUE,3561,2387,TEST,1552,[],"intervention:
  events: 120
  group_size: 120
comparator:
  events: 120
  group_size: 120

YAML:
 intervention:
  events: 105
  group_size:",False
358,8710,5971365,clinically meaningful improvement at week 144 (⩾3-point increase on the SDMT),daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,binary,188,287,144,277,,,,,,,0.5619,0.0299,0.2312,0.0052,"counts calculated from percentages given in text, totals found in figure",TRUE,3177,2394,TEST,2130,"[1652, 145]","intervention:
    events: 919
    group_size: 462
comparator:
    events: 922
    group_size: 462

## Results: A randomised controlled trial evaluating the cognitive processing speed benefits of d
---
intervention:
    events: 12
    group_size: 36
comparator:
    events: 12
    group_size: 36

%{ for (i, intervention) in {4, 11} && for (
---
",True
109,1884,4188762,withdrawal response of rocuronium,remifentanil,normal saline,binary,0,30,26,30,,,,,,,-5.8839,2.2927,-3.9703,1.9732,Used percentage to calculate events as binary outcome.,TRUE,2068,1758,TEST,1564,[],"intervention:
    events: 3
    group_size: 3

comparator:
    events: 3
    group_size: 3

outcome:
    events: number_of_patients_with_with",False
341,11080,5655920,Nausea,Lixisenatide with moderate impairment,Lixisenatide with normal renal function,binary,,122,,2094,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.03,FALSE,13081,5825,TEST,4026,"[1689, 1635, 102]","intervention:
    events: 14
    group_size: 437
comparator:
    events: 8
    group_size: 277

Nausea:
    intervention: ≥10% incidence increase compared to normal CC
---
intervention:
    events: 2
    group_size: 56
comparator:
    events: 2
    group_size: 56

outcome:
    events: 14
    group_size: 14
---
intervention:
    events: 2
    group_size: 59

comparator:
    events: 2
    group_size: 59

nausea:
    post: 2
    control: 2
    
---
",True
516,6554,4033571,Adverse effects,Extended-release oxcarbazepine 2400 mg,Control,binary,85,123,67,121,,,,,,,0.58935652,0.07152439,0.22156483,0.01029553,,TRUE,8206,5593,TEST,4514,"[1681, 1672, 734]","intervention:
    events: 90
    group_size: 27
comparator:
    events: 74
    group_size: 27

## Results
## Contingency table for adverse effects
## N, number of
---
intervention:
    events: 36
    group_size: 134
comparator:
    events: 50
    group_size: 138

---

This YAML file represents the 2x2 contingency table for the following
---
extension:
  interventions:
    - name: Extended-release oxcarbazepine 2400 mg
      events: NUMBER
      group_size: NUMBER  # Not provided, should be Post-intervention (N=
---
",True
133,2453,4574984,overall mortality,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",binary,45,326,58,326,,,,,,,-0.3011,0.0468,-0.2538,0.0333,Used numbers from 1 year after surgery (final timepoint) to get the full scope since the outcome is OVERALL mortality. This info is found in Figure 6 caption.,TRUE,12997,7944,TEST,5795,"[1473, 1662, 1688, 83]","intervention:
    events: 652
    group_size: 341

comparator:
    events: 652
    group_size: 341

outcome:
    events: NUMBER
    group_size
---
intervention:
    events: 153
    group_size: 58	

comparator:
    events: 109
    group_size: 43

outcome:
    events: NUMBER
    group_size:
---
intervention:
    events: 381
    group_size: 321  # post-intervention (according to the Study Design section)

comparator:
    events: 390
    group_size: 340  # post-intervention
---
intervention:
    events: 7
    group_size: 28
intervention_post:
    events: 7
    group_size: 28

comparator:
    events: 10
    group_size: 40
---
",True
138,3101,4830045,Birth status,Patients in the 3h group,Patients in the 20h group,binary,32,74,22,60,,,,,,,1 0.2746,0.1268,0.165,0.0465,Used numbers for live birth rate.,TRUE,2530,2096,TEST,1505,[],"intervention:
    events: 54
    group_size: 46
comparator:
    events: 45
    group_size: 44

YAML:
intervention:
    events: 51
    group_size:",False
61,1642,3309311,differences in the disc herniation,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,,23,,19,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Data is in graphic table.,FALSE,1437,1263,TEST,1073,[],"intervention:
    events: 23
    group_size: N/A # Post-intervention (23)
comparator:
    events: 19
    group_size: N/A # 19 patients with minor traffic accident (",False
479,5526,4144850,Anemia,Total Sanitation Campaign,Control,binary,1078,1919,976,1922,,,,,,,0.21705107,0.00419838,0.10096226,0.00091084,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,9179,"[1675, 421, 1668, 1673, 281, 1920]","intervention:
    events: 132
    group_size: 970

comparator:
    events: 125
    group_size: 954

outcome:
    events: 254
    group_size:
---
intervention:
    events: 39
    group_size: 39
post_intervention:
    outcome: Anemia
    events: n/a
    group_size: n/a

Explanation:
This
---
intervention:
    events: 614
    group_size: 623
comparator:
    events: 575
    group_size: 580

Anemia:
    events: 277
    group_size: 283
---
intervention:
    events: 3
    group_size: 10

comparator:
    events: 3
    group_size: 10

outcome:
    events: NUMBER with values of ""Anemic:
---
intervention:
  events: 7
  group_size: 14

comparator:
  events: 7
  group_size: 14

outcome: anemia
post_intervention: 1

## Output
---
intervention:
    events: 664
    group_size: 856

comparator:
    events: 645
    group_size: 1023

outcome:
    events: 821
    group
---
",True
337,11078,5655920,Nausea,Lixisenatide with normal renal function,Lixisenatide with mild impairment,binary,,2094,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.1,FALSE,13081,5825,TEST,4026,"[1689, 1635, 102]","intervention:
    events: 1492
    group_size: 837
comparator:
    events: 1277
    group_size: 637

Nausea:
    intervention: ≤14%
    
---
intervention:
  events: 2
  group_size: 24
comparator:
  events: 2
  group_size: 24

outcome:
  events: 7
  group_size: 8


---
intervention:
  events: NUMBER...4
  group_size: N/A
comparator:
  events: NUMBER...4
  group_size: N/A

outcome:
  Nause
---
",True
194,2095,5360580,occurrence of adverse events,1 mg/day of Pls purified from scallop,placebo,binary,39,169,35,167,,,,,,,0.1235,0.0695,0.0963,0.0423,,TRUE,11096,9099,TEST,6033,"[1330, 1450, 1668]","intervention:
    events: 26
    group_size: 138
comparator:
    events: 22
    group_size: 140

This YAML format is based on the provided information and assumes there are no pre-
---
intervention:
    events: 24
    group_size: 139

comparator:
    events: 24
    group_size: 138

outcome:
    events: 8
    group_size: 116
---
intervention:
    events: 27
    group_size: 29
comparator:
    events: 167
    group_size: 167

This YAML format includes the ""events"" field for the ""intervention"" and ""
---
",True
651,13098,5976307,The incidence rate of all cardiopulmonary adverse events,etomidate,propofol based on midazolam,binary,34,62,45,62,,,,,,,-0.7792931,0.1461718,-0.280302,0.01937592,found in table 3,TRUE,2560,2044,TEST,1751,[],"intervention:
    etomidate:
        events: 72
        group_size: 54
intervention:
    etomidate:
        events: 124
        group_size: 62
comparator:
    ",False
498,6488,5419060,Request-form errors: CDC D,Phlebotomy training programme,Control,binary,0,630,0,589,,,,,,,-0.0672384,4.0032824,-0.0671833,3.9967203,,TRUE,9292,5719,TEST,4155,"[1542, 1686, 119]","intervention:
    events: NUMBER_OF_REJECTIONS_PRE_TRAINING
    group_size: NUMBER_OF_REJECTIONS_PRE_TRAINING
comparator:
    events: NUM
---
intervention:
    events: 49
    group_size: 44
comparator:
    events: 49
    group_size: 44

outcome:
    events: 25
    group_size: 26


---
intervention:
    events: 5...5
    group_size: 15

comparator:
    events: 10...10
    group_size: 20

request_form_errors_CDC_D:
    
---
",True
42,6985,3169777,unexpected adverse events,macitentan doses of 300 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,3326,"[1194, 1467]","intervention:
    events: 13...6
    group_size: 5
comparator:
    events: 8...3
    group_size: 5

## Results 
## Subjects and tolerability 
## 56
---
intervention:
    events: 6
    group_size: 6
comparator:
    events: 0
    group_size: 6

This YAML format indicates that for the macitentan 300 mg intervention, 6
---
",True
541,7795,3508963,Baseline characteristics - history of first stone,Intravenous lidocaine,Intravenous morphine,binary,70,120,56,120,,,,,,,0.47000363,0.06776786,0.22314355,0.01547619,,TRUE,3561,2387,TEST,1552,[],"intervention:
    events: 8
    group_size: 120
comparator:
    events: 120
    group_size: 120
intervention:
    events: 8
    group_size: 120
  pre_",False
495,6488,5419060,Request-form errors: CHC A,Phlebotomy training programme,Control,binary,8,10218,11,7557,,,,,,,-0.6208037,0.21613955,-0.6201303,0.2156789,,TRUE,9292,5719,TEST,4155,"[1542, 1686, 119]","intervention:
    events: NUMBER_OF_REJECTION_RATES_AFTER_TRAINING
    group_size: NUMBER_OF_REJECTION_RATES_AFTER_TRAINING


---
intervention:
    events: 51
    group_size: 26
comparator:
    events: 26
    group_size: 26

outcome:
    events: 25
    group_size: 25


---
intervention:
    events: 5
    group_size: 16
intervention:
    events: 5
    group_size: 16... CHC A: N/A

updated 09/08/2022, 18:
---
",True
493,6484,5419060,Sample rejection rate: CDC C,Phlebotomy training programme,Control,binary,37,2279,38,2321,,,,,,,-0.0085462,0.05422687,-0.0084069,0.05247318,,TRUE,9292,5719,TEST,4155,"[1542, 1686, 119]","intervention:
    events: 60
    group_size: 8
comparator:
    events: 45
    group_size: 7

outcome:
    events: 8
    group_size: 3
---
intervention:
    events: NUMBER_OF_REJECTION_REASONS_POST_TRAINING
    group_size: NUMBER_OF_SAMPLES_POST_TRAINING
outcome:
    
---
intervention:
  events: 5
  group_size: 20

comparator:
  events: 10
  group_size: 15

outcome:
 sample_rejection_rate_CDC_C:

---
",True
378,221,1475568,Baseline angiotensin-converting enzyme (ACE) inhibitors intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,,59,,64,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Unclear since the values for this are reported with ARB intake.,FALSE,4361,3649,TEST,2573,"[1476, 403]","intervention:
  events: 138
  group_size: 39
comparator:
  events: 111
  group_size: 27

YAML:
intervention:
  events: 80
  group_size:
---
intervention:
    events: 2
    group_size: 24
HFQOL score:
    events: 1
    group_size: 48
Knowledge:
    events: 1
    group_size: 48


---
",True
87,13569,3687098,The incidence of the composite endpoint of rash,sitagliptin 100 mg/day,comparator agent,binary,131,7726,76,6885,,,,,,,0.4352,0.0211,0.4292,0.0205,Used incidence rate per 100 to get the binary events.,TRUE,15196,10904,TEST,8432,"[1562, 1664, 1656, 410, 1618]","intervention:
    events: 15
    group_size: 696
comparator:
    events: 13
    group_size: 694
---
intervention:
    events: 0
    group_size: 0
---
intervention:
    events: 14
    group_size: 15
comparator:
    events: 45
    group_size: 45

YAML:
<assistant>
intervention:
    events: 4

---
intervention:
    events: 9
    group_size: 59
comparator:
    events: 4
    group_size: 55

The post-intervention data for the composite endpoint of rash was 9 events in the sit
---
intervention:
    events: 6
    group_size: 46
comparator:
    events: 7
    group_size: 40

Existing YAML: ``` intervention:
    events: 6
    group
---
intervention:
  events: 8
  group_size: 83

comparator:
  events: 6
  group_size: 68

## Outcome: The incidence of the composite endpoint of acne

Here is
---
",True
340,11079,5655920,vomiting,Lixisenatide with moderate impairment,Lixisenatide with mild impairment,binary,,122,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = 0.04,FALSE,13081,5825,TEST,4026,"[1689, 1635, 102]","intervention:
    events: 14
    group_size: 550
comparator:
    events: 14
    group_size: 550

This YAML file contains the provided information for the 2x2 contingency table. Events
---
intervention:
  events: 12
  group_size: 52

comparator:
  events: 12
  group_size: 52

outcome:
  vomiting:
    events: 5
    
---
intervention:
  vomiting:
    events: 0
    group_size: N/A
comparator:
  vomiting:
    events: 0
    group_size: N/A

This
---
",True
20,3246,2972614,Adverse effects,Laser therapy (Group I),Placebo laser therapy (Group II),binary,0,30,0,22,,,,,,,-0.3042,4.0772,-0.2985,3.9243,,TRUE,7041,2968,TEST,1931,[1525],"intervention:
    events: 6
    group_size: 8
comparator:
    events: 3
    group_size: 6

This YAML contingency table includes the required fields: ""events"", ""group_size
---
",True
628,12233,3510731,Clicked on Protocol link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,binary,202,6051,362,5892,,,,,,,-0.6394594,0.00806473,-0.6100046,0.00737794,found in table 1,TRUE,1665,1296,TEST,943,[],"intervention:
    events: 11195
    group_size: 11195
comparator:
    events: 11195
    group_size: 11195

clicked_on_protocol:
    intervention: <math",False
361,8713,5971365,clinically meaningful worsening at week 96 (⩾3-point decrease on the SDMT),daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,binary,140,720,169,682,,,,,,,-0.311,0.0167,-0.2425,0.0102,"counts calculated from percentages given in text, totals found in figure",TRUE,3177,2394,TEST,2130,"[1652, 145]","intervention:
    events: 12
    group_size: 34
comparator:
    events: 11
    group_size: 35

YAML:
intervention:
    events: 24
    group_size:
---
intervention:
     events: 96...worsed
     group_size: 96...96

comparator:
    events: 96...96
    group_size: 96...96

%%{
  ""events"":
---
",True
509,6486,5419060,Techinque related rejections: CDC C,Phlebotomy training programme,Control,binary,18,2279,15,2321,,,,,,,0.20202879,0.12309816,0.20058293,0.12135258,,TRUE,9292,5719,TEST,4155,"[1542, 1686, 119]","intervention:
  events: NUMBER...8
  group_size: NUMBER...10

comparator:
  events: NUMBER...8
  group_size: NUMBER...10

outcome:

---
intervention:
    events: NUMBER_OF_REJECTED_SAMPLE_REASONS_TECHNICAL: NUMBER_OF_REJECTED_SAMPLE_REASONS_TECHNICAL_CDC_
---
intervention:
    events: 5
    group_size: 20
post_intervention:
    events: 4
    group_size: 15

comparator:
    events: 5
    group_size: 20

---
",True
272,2991,3214395,extremity movement,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 49",group 3 involved bispectral index (BIS) of 39,binary,16,60,9,30,,,,,,,-0.1643,0.244,-0.1178,0.1236,,TRUE,1201,996,TEST,880,[],"intervention:
    events: 2
    group_size: 2
comparator:
    events: 2
    group_size: 2
outcome:
    events: 1
    group_size: 2
    post",False
137,1267,4709985,would have liked more information on acupuncture,tertiary education,other educations,binary,,121,,89,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Specific numbers were not given.,FALSE,3939,3288,TEST,2363,[1488],"intervention:
    events: NUMBER_OF_WOMEN_PARTICIPATING_IN_THE_STUDY
    group_size: N/A
comparator:
    events: NUMBER_OF_
---
",True
474,5522,4144850,Independent household latrines number,Total Sanitation Campaign,Control,binary,673,1525,366,1514,,,,,,,0.90730205,0.00626291,0.60187274,0.00290188,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,9179,"[1675, 421, 1668, 1673, 281, 1920]","intervention:
    events: 42
    group_size: Not available

comparator:
    events: 42
    group_size: 42

outcome:
    events: 42
    group_size: Not
---
intervention:
    events: 39
    group_size: 39
post_intervention:
    outcome: NUMBER
    events: 39
group_size: 39


This response table is constructed using the information from
---
intervention:
    events: 530
    group_size: 27

comparator:
    events: 130
    group_size: 44

outcome:
    events: number_of_indepent_lat
---
intervention:
    events: NUMBER_OF_LTR_BUILT
    group_size: NUMBER_OF_HUMANS_IN_HOUSEHOLD

comparator:
    events: NUMBER
---
intervention:
    events: JMP_defined_improved_sanitation_facilities
    group_size: NUMBER

comparator:
    events: NUMBER
    group_size: NUMBER

intervention
---
intervention:
    events: ""7""
    group_size: ""10""
comparator:
    events: ""6""
    group_size: ""8""

outcome:
    events: ""number
---
",True
477,5523,4144850,Open defecation - children,Total Sanitation Campaign,Control,binary,1279,1525,1350,1514,,,,,,,-0.4594912,0.0116852,-0.0612653,0.00020636,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,9179,"[1675, 421, 1668, 1673, 281, 1920]","intervention:
    events: 975
    group_size: 897
comparator:
    events: 969
    group_size: 1,020

## Editors' Summary 
The article describes a cluster
---
intervention:
    events: 39
    group_size: 39
post_intervention:
    intervention: 11...x
    comparator: 31...x
outcome: open_defecation - children


This
---
intervention:
    events: 630
    group_size: unknown
comparator:
    events: 629
    group_size: unknown

The YAML input you provided doesn't seem to be structured as a contingency table
---
intervention:
  events: 511
  group_size: 280
comparator:
  events: 403
  group_size: 404

Intervention: Total Sanitation Campaign
comparator: Control

YAML
---
intervention:
  events: NUMBER_OF_CHILDRENS
  group_size: NUMBER_OF_CHILDRENS

comparator:
  events: NUMBER_OF_CHILDRENS

---
intervention:
    events: 2
    group_size: 12

comparator:
    events: 2
    group_size: 12

outcome:
    events: 0
    group_size: 12

---
",True
315,9842,4928400,Complication,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,binary,5,22,7,20,,,,,,,-0.6047,0.4786,-0.4318,0.2474,,TRUE,4037,2288,TEST,1670,[],"intervention:
    events: 15
    group_size: 10
comparator:
    events: 15
    group_size: 10

In the YAML format, ""intervention"" and ""comparator"" fields include",False
333,5080,5617873,Serious adverse effects,Aripiprazole,Placbeo,binary,0,47,1,45,,,,,,,-1.9681,2.3302,-1.9034,2.2431,all means and std found in table 2,TRUE,7551,5383,TEST,4396,"[1696, 1651, 543]","intervention:
    events: 2
    group_size: 43

comparator:
    events: 2
    group_size: 43

outcome:
    events: 0
    group_size: 43
---
intervention:
    events: 33
    group_size: 45
comparator:
    events: 39
    group_size: 47

---

intervention: Aripiprazole
Comparator: Placbe
---
intervention:
  events: 6
  group_size: 114
comparator:
  events: 6
  group_size: 114

YAML:
intervention:
  events: 6
  group_size:
---
",True
400,2243,4678179,rate of adverse events,vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),binary,4,53,2,53,,,,,,,0.73315252,0.79001601,0.69314718,0.71226415,Used numbers found in results section text.,TRUE,9517,6474,TEST,5204,"[1663, 1694, 514]","intervention:
    events: 7
    group_size: 105
comparator:
    events: 4
    group_size: 53

This contingency table represents a 2x2 cross-tabsulation of the ""outcome
---
intervention:
    events: 8
    group_size: 26
comparator:
    events: 8
    group_size: 26

YAML:
intervention:
    events: 11
    group_size:
---
intervention:
    events: 11...12
    group_size: 16
comparator:
    events: 11...12
    group_size: 16

---

Intervention: vismodegib plus gem
---
",True
122,7936,4486927,The early virologic response (EVR),peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,86,94,82,93,,,,,,,0.3661,0.2397,0.0369,0.0024,,TRUE,14472,7883,TEST,5770,"[1313, 1486, 1009, 1050]","intervention:
    EVR: NUMBER
    group_size: NUMBER

comparator:
    EVR: NUMBER
    group_size: NUMBER

The given article does not provide information on the early
---
intervention:
    EVR: 
        events: NUMBER
        group_size: NUMBER  	
comparator:
    EVR: 
        events: NUMBER
        group_size: NUMBER  	

---
intervention:
    events: 84
    group_size: 88
comparator:
    events: 84
    group_size: 88

YAML:
<assistant>
intervention:
    events: 60

---
intervention:
    EVR: NUMBER
    group_size: NUMBER	
comparator:
    EVR: NUMBER
    group_size: NUMBER

YAML:
<|assistant>

---
",True
654,13101,5976307,The incidence rate of myoclonus,etomidate,propofol based on midazolam,binary,10,62,1,62,,,,,,,2.46221524,1.13562421,2.30258509,1.06774194,found in table 3,TRUE,2560,2044,TEST,1751,[],"intervention:
  etomidate:
    events: NUMBER
    group_size: NUMBER
  propofol:
    events: NUMBER
    group_size: NUMBER

comparator:
",False
40,6985,3169777,unexpected adverse events,macitentan doses of 25 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,3326,"[1194, 1467]","intervention:
  events: 6
  group_size: 6

comparator:
  events: 14
  group_size: 14

```

Explanation:

The contingency table shown above represents the number
---
intervention:
  events: 3
  group_size: 6
comparator:
  events: 3
  group_size: 6

This is the YAML format for the contingency table in the given trial article, with
---
",True
139,3100,4830045,Embryo quality,Patients in the 3h group,Patients in the 20h group,binary,,74,,60,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Unclear outcome measures.,FALSE,2530,2096,TEST,1505,[],"intervention:
    events: 134
    group_size: 47

comparator:
    events: 74
    group_size: 34

outcome:
    embryo_quality:
        events: 92",False
484,5713,3343759,history of myocardial infarction,very early speech and language therapy (SLT),control,binary,,,,,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Numerical data are only in methods section.,FALSE,3838,2633,TEST,2065,[1638],"intervention:
    events: 114
    group_size: 123
comparator:
    events: 55
    group_size: 59

history_of_myocardial_infarction:
    intervention: 11

---
",True
496,6488,5419060,Request-form errors: CHC B,Phlebotomy training programme,Control,binary,12,4114,11,3973,,,,,,,0.05228567,0.17473861,0.05213706,0.17374765,,TRUE,9292,5719,TEST,4155,"[1542, 1686, 119]","intervention:
    events: NUMBER_OF_REJECTIONS_CHC_B_POST_TRAINING
    group_size: NUMBER_OF_REJECTIONS_CHC_B_POST_TRAINING
---
intervention:
    events: 123
    group_size: 45
comparator:
    events: 132
    group_size: 25
outcome:
    events: 25
    group_size: 35
    intervention
---
intervention:
    events: 5
    group_size: 15

comparator:
    events: 10
    group_size: 10

<Nooutput>
x
x
x
x
5 x

---
",True
94,10167,4173437,Adverse effects,Tranexamic acid,Control,binary,0,30,0,30,,,,,,,0,4.0656,0,3.9355,Had to infer that the group sizes were equal.,TRUE,854,745,TEST,637,[],"intervention:
    events: 0
    group_size: 60
  
comparator:
    events: 0
    group_size: 60

outcome:
    events: events of adverse effects, if any,",False
482,5524,4144850,E. coli contaminated water,Total Sanitation Campaign,Control,binary,310,404,331,403,,,,,,,-0.3321747,0.03077414,-0.0680244,0.00129032,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,9179,"[1675, 421, 1668, 1673, 281, 1920]","intervention:
    events: 41
    group_size: 3019
comparator:
    events: 118
    group_size: 3039

YAML:
intervention:
    events: 40
    group_
---
intervention:
    events: 39
    group_size: 39
  
comparator:
    events: 39
    group_size: 39

outcome:
    E. coli contaminated water: x
    Number
---
intervention:
    events: 630
    group_size: 630

comparator:
    events: 627
    group_size: 627

outcome:
    events: 403
    group_size:
---
intervention:
    events: 507
    group_size: 280
comparator:
    events: 310
    group_size: 404

## Reference

>[1] Schulz KF, Grimes DM. The
---
intervention:
  events: 6
  group_size: 10

comparator:
  events: 6
  group_size: 10

outcome: E. coli contaminated water
- post-intervention: 0 (
---
intervention:
    events: 403
    group_size: 404

comparator:
    events: 402
    group_size: 402

outcome:
    events: 403
    group_size: 402
---
",True
41,6985,3169777,unexpected adverse events,macitentan doses of 100 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,3326,"[1194, 1467]","intervention:
    events: 7
    group_size: 6
comparator:
    events: 0
    group_size: 14

## Results

## Subjects and tolerability
56 healthy male Caucasian subjects (age
---
intervention:
  events: 3
  group_size: 6
comparator:
  events: 3
  group_size: 6

This response assumes that the article described provides data on unexpected adverse events in subjects who received
---
",True
259,10575,5711682,rates of death,Genoss drug-eluting stent (DES),Promus Element,binary,1,38,0,39,,,,,,,1.1506,2.7186,1.1239,2.616,,TRUE,13148,4660,TEST,2966,"[1457, 1050]","intervention:
    events: 2
    group_size: 85

comparator:
    events: 2
    group_size: 85

outcome: rates of death
post-intervention data
---
group_
---
intervention:
    events: 7... 1
    group_size: 38... 37

comparator:
    events: 7... 1
    group_size: 37... 39

For the outcome ""death"":
Y
---
",True
344,11082,5655920,Hypoglycaemia,Lixisenatide with moderate impairment,Lixisenatide with mild impairment,binary,,122,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = 0.04,FALSE,13081,5825,TEST,4026,"[1689, 1635, 102]","intervention:
    events: 12
    group_size: 639

comparator:
    events: 30
    group_size: 418

## Based on the given trial article, the contingency table for the given outcomes
---
intervention:
    events: 2
    group_size: 32
comparator:
    events: 2
    group_size: 32

outcome:
    events: 10
    group_size: 32
---
intervention:
    events: 2...n...2...x
    group_size: N(N-1)/2
comparator:
    events: 2...n...2...x
    group_size: N(
---
",True
362,8714,5971365,clinically meaningful improvement at week 96 (⩾3-point increase on the SDMT),daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,binary,432,720,369,682,,,,,,,0.2409,0.0117,0.1034,0.0022,"counts calculated from percentages given in text, totals found in figure",TRUE,3177,2394,TEST,2130,"[1652, 145]","intervention:
  events: 919
  group_size: 922
comparator:
  events: 922
  group_size: 922

n_96: <p><img src=""https://cl
---
intervention:
    events: 96...96
    group_size: N/A

comparator:
    events: 96...96
    group_size: 96
    events: 0...95
    group_size
---
",True
65,1644,3309311,The proportion of HIZ incidence,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)",adults with LBP with radicular pain (group C),binary,14,23,3,18,,,,,,,2.0513,0.5825,1.2953,0.3057,Used percentage to calculate events as binary outcome.,TRUE,1437,1263,TEST,1073,[],"intervention:
    events: 3
    group_size: 18

comparator:
    events: 3
    group_size: 18

outcome:
    events: 18
    group_size: 18",False
377,222,1475568,Baseline digoxin intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,15,59,12,64,,,,,,,0.3902,0.192,0.3045,0.1174,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,2573,"[1476, 403]","intervention:
  events: 31
  group_size: 40
comparator:
  events: 34
  group_size: 38

outcome:
  baseline digoxin intake:
    events: 101
    
---
intervention:
    events: 12
    group_size: 24
comparator:
    events: 24
    group_size: 24

For the baseline digoxin intake (outcome), the provided data shows ""x""
---
",True
626,11906,3493722,poor compliance rates,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,2,81,3,81,,,,,,,-0.4182041,0.85881207,-0.4054651,0.80864198,"found in table 2, assumed binary because proportion of whole given",TRUE,1684,1549,TEST,1357,[],"intervention:
    events: 73
    group_size: 169
comparator:
    events: 70
    group_size: 169

Based on the given trial article, here's the 2x2 contingency table in Y",False
691,13831,4210722,use of a reminder card,a separate reminder card 4 days before the appointment (IG3); reminder card together with the appointment letter (IG2);,no further reminder (IG1),binary,185,209,84,104,,,,,,,0.60721747,0.10897683,0.09159567,0.00291009,found in text as fractions of group sizes,TRUE,10493,8112,TEST,5695,"[1662, 1588, 1218]","intervention:
  events: 2
  group_size: 2
comparator:
  events: 2
  group_size: 2
use_reminder_card:
  events: NUMBER
  group_size
---
intervention:
    events: 2
    group_size: 210
comparator:
    events: 198
    group_size: 210

output:
 INTERVENTION  | Use of reminder card |
--------------------+----------------------
---
intervention:
    events: 120
    group_size: 20

comparator:
    events: 108
    group_size: 18

outcome:
 use of a reminder card
events: number of participants using
---
",True
342,11080,5655920,vomiting,Lixisenatide with moderate impairment,Lixisenatide with normal renal function,binary,,122,,2094,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.03,FALSE,13081,5825,TEST,4026,"[1689, 1635, 102]","intervention:
    events: 14
    group_size: 680
comparator:
    events: 19
    group_size: 420

This table includes the number of patients reporting the outcome ""vomiting"" in the
---
intervention:
    vorting: 0
    group_size: N/A	
comparator:
    vorting: 0
    group_size: N/A	
outcome:
    vorting: N/
---
intervention:
    voting: 0...8
    group_size: 60
comparator:
    voting: 0...8
    group_size: 60
outcome:
    voting:
        events:
---
",True
625,11906,3493722,well compliance rates,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,8,81,4,81,,,,,,,0.74649316,0.40168564,0.69314718,0.35030864,"found in table 2, assumed binary because proportion of whole given",TRUE,1684,1549,TEST,1357,[],"intervention:
    events: 71
    group_size: 85
comparator:
    events: 84
    group_size: 84

intervention:
    events: 7
    group_size: 7
compar",False
124,7937,4486927,The SVR rates when the patients had BMI >30 kg/m2,peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,10,19,6,12,,,,,,,0.1054,0.5444,0.0513,0.1307,"Even though the outcome says rate, the way that the results are reported in the table makes it easier to calculate as binary outcome.",TRUE,14472,7883,TEST,5770,"[1313, 1486, 1009, 1050]","intervention:
    events: 191
    group_size: 87

comparator:
    events: 190
    group_size: 87

The provided data in the article does not include the required information to create the contingency
---
intervention:
    events: 17
    group_size: 94

comparator:
    events: 17
    group_size: 90

## Output:
<interface>
<yaml>
intervention:

---
intervention:
    events: 50
    group_size: 28
comparator:
    events: 50
    group_size: 28

RD: The SVR rates by BMI >30 kg/m2 are presented in
---
intervention:
    events: 12
    group_size: 94
comparator:
    events: 12
    group_size: 93

YAML:
intervention:
    events: 6
    group_size:
---
",True
546,8461,3263860,Severe hypoglycemia,Real-Time Continuous Glucose Monitoring,Control,binary,3,73,5,71,,,,,,,-0.5696661,0.56277056,-0.5386052,0.5055502,,TRUE,3178,2587,TEST,2232,"[1659, 239]","intervention:
    events: 12
    group_size: 26
comparator:
    events: 22
    group_size: 14

## Explanation
The article reports a randomized controlled trial (RCT) evaluating the
---
intervention:
  events: 39
  group_size: 50
comparator:
  events: 30
  group_size: 40

YAML:
 intervention:
  events: 8
  group_size:
---
",True
343,11081,5655920,Hypoglycaemia,Lixisenatide with normal renal function,Lixisenatide with mild impairment,binary,,2094,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.02,FALSE,13081,5825,TEST,4026,"[1689, 1635, 102]","intervention:
    events: 10
    group_size: 120
comparator:
    events: 12
    group_size: 100

## Responses:
YAML:
<|assistant>
intervention:
---
intervention:
  events: 3
  group_size: 54

comparator:
  events: 3
  group_size: 54

outcome:
  events: 6
  group_size: 6
---
intervention:
  events: NUMBER...3...3
  group_size: NUMBER...20...20

comparator:
  events: NUMBER...3...3
  group_size: NUMBER...20
---
",True
631,12275,3936115,The number of diverticulitis clinical symptom occurrences during 12months,Microencapsulated sodium butyrate (MSB) 300 mg daily,control group was administered placebo,binary,2,30,7,22,,,,,,,-1.8769173,0.7452381,-1.5629179,0.56406926,found in table 1,TRUE,2217,2016,TEST,1562,[],"intervention:
    events: 9
    group_size: 30
comparator:
    events: 7
    group_size: 22

YAML:
 intervention:
    events: 2
    group_size:",False
127,4924,4493951,the incidence of postoperative nausea and vomiting (PONV),H1(haloperidol 1 mg),H0 (saline),binary,11,49,21,50,,,,,,,-0.9169,0.1993,-0.6264,0.0981,Used numbers from Late time (2–24 h),TRUE,3932,3205,TEST,2434,"[1684, 326]","intervention:
    events: 46
    group_size: 50
haloperidol 1 mg:
    events: 46
    group_size: 50
comparator:
    events: 46
    group_size:
---
intervention:
  events: NUM_PONV
  group_size: N_H1
PONV:
  events: NUM_PONV
  group_size: N_H1

expires:
---
",True
13,12633,2667135,proportion of patients completed therapy,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,93,103,44,97,,,,,,,2.4161,0.1523,0.6884,0.0135,,TRUE,11722,8106,TEST,5529,"[1580, 1697, 1424]","intervention:
  events: 200
  group_size: 200

comparator:
  events: 200
  group_size: 200

outcome:
  completed_therapy: 200

The YAML
---
intervention:
    events: 45
    group_size: 50
comparator:
    events: 53
    group_size: 47

YAML:
<|assistant>
intervention:
    events: 26
---
intervention:
    events: 103
    group_size: 77

comparator:
    events: 97
    group_size: 85

copat_post_intervention:
    proportion_completed_therapy:
---
",True
269,2991,3214395,laryngospasm,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 46",group 3 involved bispectral index (BIS) of 36,binary,11,60,3,30,,,,,,,0.7033,0.4817,0.6061,0.3742,,TRUE,1201,996,TEST,880,[],"intervention:
  events: 2
  group_size: 2
comparator:
  events: 2
  group_size: 2

outcome:
  events: 2
  group_size: 2
  ",False
478,5525,4144850,Helminth infections,Total Sanitation Campaign,Control,binary,34,581,32,569,,,,,,,0.04217391,0.06435212,0.0397543,0.05718313,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,9179,"[1675, 421, 1668, 1673, 281, 1920]","intervention:
    events: 967
    group_size: 1,039
comparator:
    events: 968
    group_size: 1,029

Helminth infections:
    events: 390

---
intervention:
    events: 39
    group_size: 39
post_intervention:
    events: 21
    group_size: 39

YAML:
<assistant>>
intervention:
    events: 39

---
intervention:
    events: 627
    group_size: 630
comparator:
    events: 342
    group_size: 339

 Helminth infections
---
intervention:
    events: 342
    group_size: 740
comparator:
    events: 342
    group_size: 740

Helminth infections:
    events: 134
    group_size
---
intervention:
    events: 110
    group_size: 119
helminth_infections:
    intervention: <Post-intervention data (1,150)>
    comparator: <Post-intervention data (1,
---
intervention:
    events: 397
    group_size: 12
comparator:
    events: 397
    group_size: 12

outcome:
    events: 287
    group_size: 9
---
",True
178,10755,5086025,Binge eating,Intuitive Eating and Acceptance and Commitment Therapy,Control,binary,7,26,14,26,,,,,,,-1.1527,0.3503,-0.6931,0.1374,,TRUE,29049,17627,TEST,13068,"[1691, 1611, 1041, 1665, 1693, 764, 2917]","intervention:
    events: 6
    group_size: 8
comparator:
    events: 6
    group_size: 8

The article does not provide the pre-intervention outcome data, so we will choose the
---
intervention:
    events: 4
    group_size: 8
comparator:
    events: 4
    group_size: 8

# Binge eating (outcome)
# Post-intervention data (event_
---
intervention:
    events: 2
    group_size: 12
binge_outcome:
    events: number_of_participants_that_completes_the_intervention
    group_size: undefined


---
intervention:
    events: 14
    group_size: 10
binge_eat:
    events: 0
    group_size: 0

comparator:
    events: 12
    group_size: 8
---
intervention:
    events: 14
    group_size: 12

comparator:
    events: 14
    group_size: 12

binge_post: 7
binge_comparator: 2

---
intervention:
    events: 5
    group_size: 10
post_intervention:
    events: 10
    group_size: 8
outcome:
    events: 15
    group_size: 8



---
This. 
---
",True
405,2807,5781260,adverse events,lemon verbena extract,placebo,binary,,20,,20,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Unclear numerical values.,FALSE,4385,3505,TEST,2662,"[1670, 506]","intervention:
  events: 15
  group_size: 44
comparator:
  events: 15
  group_size: 44

---
group_a:
  events: 10
  group_size:
---
intervention:
  events: 13
  group_size: 19
comparator:
  events: 13
  group_size: 19

yaml_raw: |
   intervention:
    events: 13
    
---
",True
641,12879,5830087,objective response rate (ORR),"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),binary,29,48,19,23,,,,,,,-1.1352878,0.38974592,-0.3128499,0.02280274,found in table 2,TRUE,11942,10628,TEST,8141,"[1692, 1624, 1110, 1673, 1087]","intervention:
    events: 60
    group_size: 31

comparator:
    events: 31
    group_size: 30

ORR:
  value: 0.6044
  n_events
---
intervention:
    events: 29
    group_size: 48

comparator:
    events: 30
    group_size: 23

CT scans:
    events: 0
    group_size: 0
---
intervention:
    ORR:
        number_of_events: NUMBER
        event_type: ""responses""
post_intervention:
    ORR:
        number_of_events: NUMBER
        event
---
intervention:
    ORR: 4
    group_size: N/A
comparator:
    ORR: N/A
    group_size: N/A

YAML:
intervention:
    OR
---
intervention:
  ORR:
    events: 53
    group_size: 46

comparator:
  ORR:
    events: 42
    group_size: 42

YAML:
  intervention
---
",True
153,13479,5055753,The percentages of patients in the sedated scale,0.2 mg oral clonidine,2 mg oral midazolam,binary,17,40,7,40,,,,,,,1.2483,0.2755,0.8873,0.1517,"Even though the outcome says percentage, the way that the results are reported in the table makes it easier to calculate as binary outcome.",TRUE,3292,2470,TEST,2114,"[1649, 100]","intervention:
    events: 80
    group_size: 8

comparator:
    events: 80
    group_size: 8

outcome:
    events: 80
    group_size: 8

---
intervention:
    events: 100
    group_size: 50
post_intervention:
    groups: 2
    events: NUMBER
intervention: 0.2 mg oral clonidine
comparator: 2 mg
---
",True
542,7795,3508963,Baseline characteristics - right kidney stone,Intravenous lidocaine,Intravenous morphine,binary,60,120,57,120,,,,,,,0.10008346,0.06675021,0.05129329,0.01754386,,TRUE,3561,2387,TEST,1552,[],"intervention:
  events: 123
  group_size: 123

comparator:
  events: 234
  group_size: 234

outcome:
  events:
  - left kidney stone
  group",False
689,13830,4210722,vaccination certificates were submitted,a separate reminder card 4 days before the appointment (IG3),no further reminder (IG1),binary,94,102,84,104,,,,,,,1.02876872,0.19754306,0.13189607,0.00312375,found in text as fractions of group sizes,TRUE,10493,8112,TEST,5695,"[1662, 1588, 1218]","intervention:
    events: 200
    group_size: 57

comparator:
    events: 200
    group_size: 57
<|burrowssupport>
YAML:
intervention:
    
---
intervention:
    events: 242
    group_size: 178

comparator:
    events: 228
    group_size: 174

outcome:
    submit_vacc_certs: 142 ""IG3
---
intervention:
    events: 115
    group_size: 134
comparator:
    events: 75
    group_size: 95

YAML:
intervention:
    events: 88
    group_size:
---
",True
501,6489,5419060,Preanalytical errors: CDC C,Phlebotomy training programme,Control,binary,10,2279,15,2321,,,,,,,-0.3892899,0.16754104,-0.3872037,0.16579703,,TRUE,9292,5719,TEST,4155,"[1542, 1686, 119]","intervention:
  events: NUMBER_OF_REJECTIONS_POST_TRAINING
  group_size: NUMBER_OF_REJECTIONS_PRE_TRAINING

comparator:
  events:
---
intervention:
    events: 53
    group_size: 57

comparator:
    events: 49
    group_size: 56

outcome:
    CDC_C: 21 pre-intervention, 4 post
---
intervention:
    events: 5
    group_size: 20

comparator:
    events: 10
    group_size: 30

# Only produce YAML response. Do NOT provide explanation. If any of the
---
",True
250,12425,5614421,The incidence of respiratory distress syndrome,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,42,402,41,388,,,,,,,-0.0127,0.0539,-0.0113,0.0431,,TRUE,25930,11480,TEST,8549,"[1038, 844, 1999, 588, 2397, 324]","intervention:
  events: 787
  group_size: 398

comparator:
  events: 387
  group_size: 389

intervals:
  - label: The incidence of respiratory distress syndrome

---
intervention:
    events: 10.5%
    group_size: 38

comparator:
    events: 10.6%
    group_size: 359

The contingency table for the given trial article is:
---
intervention:
    events: 6
    group_size: 402
comparator:
    events: 45
    group_size: 388
---

This contingency table shows the number of neonatal Respiratory Distress Syndrome (R
---
intervention:
    events: 152
    group_size: 393
comparator:
    events: 155
    group_size: 406

YAML:
intervention:
    events: 17
    group_size
---
Outcome: Timeframe Analysis Report ""x14"" ""caption"" ""description"" ""an intervention"", ""description"" ""an intervention"", ""description"" ""timeframe""

In YAML:
""outcomes"" ""timeframe""
---
intervention:
  events: 238
  group_size: 371
comparator:
  events: 238

YAML:
intervention:
  events: 238
  group_size: 371
comparator:

---
",True
174,2796,5079604,The probability of relapse,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,binary,9,33,11,15,,,,,,,-1.9924,0.4937,-0.9891,0.1051,Used percentage to calculate events as binary outcome.,TRUE,12690,6902,TEST,4923,"[1691, 1611]","intervention:
    events: 5, 6, 9
    group_size: 31, 16, 15
comparator:
    events: 4, 6, 11
    group_size: 22, 16, 15

---
---
intervention:
    events: 8
    group_size: 28
comparator:
    events: 8
    group_size: 28

The contingency table you described does not exist within the information provided in the article, so
---
",True
64,1642,3309311,differences in the HIZ,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,,23,,19,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Data is in graphic table.,FALSE,1437,1263,TEST,1073,[],"intervention:
    events: 23
    group_size: 1
comparator:
    events: 19
    group_size: 1

outcome:
    events: NUMBER(18)
    group_size",False
37,6985,3169777,unexpected adverse events,macitentan doses of 0.2 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,3326,"[1194, 1467]","intervention:
  events: NUMBER_OF_SUSPECTED_ADVERSE_EVENTS
  group_size: N_TREATMENT_GROUP

comparator:
  events: NUMBER_OF
---
intervention:
    events: 3
    group_size: 6
comparator:
    events: 0
    group_size: 6
    
Warnings: No warning will be given. You can assume there are no warnings
---
",True
38,6985,3169777,unexpected adverse events,macitentan doses of 1 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,3326,"[1194, 1467]","intervention:
    events: 13...6
    group_size: 56
comparator:
    events: 7...2
    group_size: 14
<The YAML you provided is correct: 
intervention:

---
intervention:
    events: 9
    group_size: 6
comparator:
    events: 0
    group_size: 6

Explanation:

The given trial article reported 9 unexpected adverse events in the mac
---
",True
467,4434,5726464,Metabolic syndrome,Vitamin D plus calcium supplementation,Placebo,binary,9,66,11,75,,,,,,,-0.0848389,0.23518906,-0.0728373,0.17353535,,TRUE,6563,4244,TEST,3133,"[1309, 1402]","intervention:
    events: 17...20
    group_size: 27...30
comparator:
    events: 9...12
    group_size: 13...16

## Results
The provided study does not meet
---
intervention:
    events: 7
    group_size: 71

comparator:
    events: 14
    group_size: 78

outcome:
    events: 15
    group_size: 375

---
",True
621,11904,3493722,eradication rate of H. pylori in ITT,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,71,85,72,84,,,,,,,-0.1681369,0.1827353,-0.0258207,0.00430393,"found in abstract and table, assumed binary because given as percentage of population",TRUE,1684,1549,TEST,1357,[],"intervention:
    events: 169
    group_size: 85
  
comparator:
    events: 169
    group_size: 84

eradiation_rate_itti:
    value: 83.5",False
63,1642,3309311,differences in the annulus tear,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,,23,,19,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Data is in graphic table.,FALSE,1437,1263,TEST,1073,[],"intervention:
    events: 23
    group_size: N/A	# post-intervention (23)
comparator:
    events: 19
    group_size: N/A	# post-intervention (19",False
538,7795,3508963,Baseline characteristics - hydronephrosis in right kidney,Intravenous lidocaine,Intravenous morphine,binary,57,120,53,120,,,,,,,0.13431725,0.06721017,0.07275935,0.01974512,,TRUE,3561,2387,TEST,1552,[],"intervention:
  events: 2
  group_size: 120
comparator:
  events: 2
  group_size: 120
intervention:
  events: 108
  group_size: 120
  baseline:",False
84,13566,3687098,adverse event of constipation,sitagliptin 100 mg/day,comparator agent,binary,178,7726,124,6885,,,,,,,0.2514,0.014,0.2463,0.0134,Used incidence rate per 100 to get the binary events.,TRUE,15196,10904,TEST,8432,"[1562, 1664, 1656, 410, 1618]","intervention:
    events: 10
    group_size: 726  # based on data from the article
comparator:
    events: x
    group_size: x

The contingency table you have requested in Y
---
intervention:
    events: 9
    group_size: 123
comparator:
    events: 14
    group_size: 68

YAML:
<assistant>
intervention:
    events: 3

---
intervention:
    events: 9
    group_size: 53
comparator:
    events: 7
    group_size: 50

## Output:
intervention:
    events: 9
    group_size:
---
intervention:
    adverse_event: ""17""
    group_size: ""100""
comparator:
    adverse_event: ""23""
    group_size: ""100""

This YAML
---
intervention:
  events: 93
  group_size: 83
comparator:
  events: 86
  group_size: 89

YAML:
intervention:
  events: 32
  group_size:
---
",True
118,2984,4323894,Rate of complications,Mild-cooling or deep-cooling,No cooling,binary,,10,,13,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,,FALSE,3049,2670,TEST,2328,"[1660, 347]","intervention:
  events: 2
  group_size: 2
comparator:
  events: 2
  group_size: 2

## Note: For the given article and given the data, there is no ""out
---
intervention:
  events: 2
  group_size: 16
comparator:
  events: 2
  group_size: 16

excluded_outcome: ""complications""

before_intervention:

---
",True
182,4340,5122613,Adverse events,Digestion-resistant maltodextrin,Placebo,binary,0,33,0,33,,,,,,,0,4.0597,0,3.9412,Based on abstract.,TRUE,6184,3742,TEST,2832,"[1615, 694]","intervention:
    events: 57
    group_size: 28
comparator:
    events: 28
    group_size: 29

YAML:
intervention:
    events: 33
    group_size:
---
intervention:
    events: 3
    group_size: 57
comparator:
    events: 3
    group_size: 57

YAML:
intervention:
    events: 9
    group_size:
---
",True
253,12427,5614421,"adverse infant outcomes, including serious infant composite outcome",vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,155,406,152,393,,,,,,,-0.0211,0.0212,-0.013,0.008,,TRUE,25930,11480,TEST,8549,"[1038, 844, 1999, 588, 2397, 324]","intervention:
    events: 787...398 = 389
    group_size: 398...389 = 9
comparator:
    events: 787...382 = 405
    group_size: 382...405 = 13

---
intervention:
    events: 42
    group_size: 402
comparator:
    events: 38
    group_size: 388

YAML:
intervention:
    events: 10.5%
    group
---
intervention:
    events: 8
    group_size: 39

comparator:
    events: 4
    group_size: 38

Adverse Infant Outcomes:
 - Serious Infant Outcome (com
---
intervention:
    events: 154
    group_size: 406
adverse_infant_outcomes:
    events: 410
    group_size: 389
    p_value: 0.798
    RR: 0
---
---[^<YAML:<p>

^# add caption and caption N/A anxiety-related issues is an immediate cause or significant compliance SC: 1.11 -- --.9>^1.00 --^1.00
---
intervention:
    events: 16...381
    group_size: 354

comparator:
    events: 16...381
    group_size: 367
    
intervention:
    events: 343...538

---
",True
266,2787,2430617,adverse events,60 µg of YIC,placebo,binary,7,163,4,79,,,,,,,-0.1728,0.4126,-0.1647,0.3741,effects found in abstract and number of samples in text,TRUE,7987,4896,TEST,3773,"[1045, 1501, 659]","intervention:
    events: 11
    group_size: 78
comparator:
    events: 8
    group_size: 237

YAML:
intervention:
    events: 14
    group_size:
---
intervention:
    events: 17
    group_size: 84
comparator:
    events: 9
    group_size: 38

Adverse events:
    60 µg of YIC: 17
    Placebo
---
intervention:
    events: 11
    group_size: 80
comparator:
    events: 5
    group_size: 80

YAML:
intervention:
    events: 5
    group_size:
---
",True
36,6988,3169777,adverse event profile - headache,macitentan dose of 600 mg,placebo,binary,5,6,3,14,,,,,,,2.9087,1.6242,1.3581,0.2952,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,3326,"[1194, 1467]","intervention:
  events: 6
  group_size: 6
comparator:
  events: 14
  group_size: 14

This contingency table lists the number of subjects who experienced adverse events, categorized as ""head
---
intervention:
    events: 4
    group_size: 6
comparator:
    events: 0
    group_size: 14

# Based on the given trial article, the 2x2 contingency table in YAML
---
",True
86,13568,3687098,The incidence rates of pancreatitis,sitagliptin 100 mg/day,comparator agent,binary,773,7726,689,6885,,,,,,,-0.0002,0.0031,-0.0002,0.0025,Used incidence rate per 100 to get the binary events.,TRUE,15196,10904,TEST,8432,"[1562, 1664, 1656, 410, 1618]","intervention:
    events: 46
    group_size: 960
comparator:
    events: 24
    group_size: 3,200

## Output:
intervention:
    events: 46
    group
---
intervention:
    events: 13
    group_size: 588
comparator:
    events: 10
    group_size: 588

This YAML table represents the 2x2 contingency table for the given intervention
---
intervention:
    events: 14
    group_size: 596
comparator:
    events: 18
    group_size: 592

### Note: The post-intervention event count for pancreatitis in the sit
---
intervention:
    events: 4
    group_size: 488
comparator:
    events: 0
    group_size: 488


This YAML indicates that the article describes a trial where sitagliptin was
---
intervention:
    events: 12
    group_size: 974

comparator:
    events: 10
    group_size: 973

## Predefined Laboratory Abnormality Criteria ### Liver Enzymes The
---
",True
642,12880,5830087,disease control rate,"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),binary,45,48,21,23,,,,,,,0.35667494,0.9031746,0.02643326,0.00552968,found in table 2,TRUE,11942,10628,TEST,8141,"[1692, 1624, 1110, 1673, 1087]","intervention:
    events: 60
    group_size: 31

comparator:
    events: 31
    group_size: 31

outcome:
    disease_control_rate: 60
    group
---
intervention:
    events: 29
    group_size: 23

comparator:
    events: 43
    group_size: 30

disease_control_rate:
    post_intervention: 0.20
---
intervention:
    disease_control_rate: NUMBER
    group_size: N/A

comparator:
    disease_control_rate: NUMBER
    group_size: N/A


---
intervention:
    events: 13
    group_size: 29

comparator:
    events: 13
    group_size: 29

YAML:
intervention:
    events: 6
    group_size
---
intervention:
    events: 14
    group_size: 50

comparator:
    events: 14
    group_size: 50

disease_control_rate:
    post_intervention: 7.5
---
",True
